Page last updated: 2024-09-20

doxorubicin hydrochloride

Cross-References

ID SourceID
PubMed CID4112
CHEMBL ID426
CHEMBL ID_59579
CHEBI ID93775
SCHEMBL ID3712
SCHEMBL ID11986730
SCHEMBL ID20369096
MeSH IDM0006787
PubMed CID443939
CHEMBL ID359744
CHEBI ID31522
SCHEMBL ID3242
MeSH IDM0006787

Synonyms (280)

Synonym
smr001565548
HMS3267F07
l-glutamic acid, n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
NCI60_041622
BSPBIO_000210
6-mtx (dl)
n-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-dl-glutamic acid
dl-glutamic acid, n-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-
nsc 117356
glutamic acid, n-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, dl-
dl-methotrexate
n-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-dl-glutamic acid
einecs 262-213-7
dl-amethopterin
PRESTWICK_753
amethopterin (r,s)
60388-53-6
BPBIO1_000579
BPBIO1_000232
PRESTWICK3_000373
BSPBIO_001993
PRESTWICK2_000373
nsc117356
mls002701970 ,
nsc-117356
PRESTWICK3_000135
NCGC00095284-01
NCGC00095284-02
(+)-amethopterin
SPBIO_002446
PRESTWICK1_000373
PRESTWICK0_000373
SPECTRUM1500398
BSPBIO_000525
2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
AC-11680
HMS2091D16
M1664
AKOS000281496
TCMDC-123832 ,
CHEMBL426 ,
BRD-A55424491-001-07-4
HMS1920L21
HMS1569K07
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate )
bdbm50004545
(mtx)2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate, mxt)
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(amethopterin)
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (methotrexate)
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (mtx)
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(mtx)
chembl_59579
methotrexate2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate(mtx))
(methotrexate, mtx)2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
4-methyl-(1s,5r,13r,14s,17r)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(methotrexate, mtx)
2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
(methotrexate)2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid bis-adamantan-1-ylamide
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate)
2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate (mtx))
2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
HMS2096K07
nsc-757113
nsc757113
methotrexate(+/-)
pharmakon1600-01500398
NCGC00015079-03
NCGC00015079-04
(+-)-methotrexate
99ito15x8s ,
methotrexate, (+/-)-
unii-99ito15x8s
FT-0630651
FT-0601523
AB02593
HMS3371G08
CCG-212689
SCHEMBL3712
d(-)-amethopterin
AKOS024282621
(+/-)amethopterin
SCHEMBL11986730
folex (salt/mix)
n-(4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl)glutamic acid, (l)-
FBOZXECLQNJBKD-UHFFFAOYSA-N ,
kyselina 4-amino-n10-methylpteroylglutamova
4-amino-n10-methylpteroylglutamic acid
glutamic acid, n-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, l-(+)-
n-(p-((2,4-diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid, (l)-
HMS3403O03
CHEBI:93775
HMS3654M22
SR-05000001673-2
SR-05000001673-1
sr-05000001673
glutamic acid, n-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-
(+/-)-methotrexate
n-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid
SBI-0053664.P003
HMS3713K07
NCGC00015079-07
2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid
Q27165469
SCHEMBL20369096
methotrexate pound>>amethopterin
BCP02078
BRD-A55424491-001-08-2
BCP29918
amethopterin; dl-amethopterin
HMS3869E13
methotrexate;dl-amethopterin
n-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid
DTXSID40859034
dl-mtx
EN300-296152
glutamic acid, n-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioicacid
bdbm50600679
adriamycin, hydrochloride
hydroxydaunorubicin hydrochloride
adriamycin hydrochloride
adm hydrochloride
fi 6804
adriacin
liposomal doxorubicin hydrochloride
adriablastina cs
hydroxydaunomycin hydrochloride
doxorubicini hydrochloridum
CHEMBL359744
MLS000070047
doxorubicin hydrochloride
PRESTWICK_188
smr000058570
MLS000049970
MLS000049971
MLS000049969
NCGC00024415-36
adriblastine
hydrochloride, doxorubicin
25316-40-9
MLS000392861
MLS000392871
MLS000392881
MLS000392891
MLS000392901
NCGC00024415-33
MLS001401460 ,
MLS001055359
adriamycin rdf
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8s-cis)-
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8s-cis)-
einecs 246-818-3
kw-125
adriamycin pfs
adriblastina rd
(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
doxorubicin hcl
(8s,10s)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
rubex
lipodox
ccris 740
caelyx
doxorubicin hydrochloride (liposomal)
doxorubicin hydrochloride [jan]
DOX ,
doxorubicin hydrochloride, 98.0-102.0% (hplc)
MLS000759533
cpd000058570 ,
adriamycin (tn)
rubex (tn)
doxil (tn)
doxorubicin hydrochloride (jp17/usp)
adriacin (tn)
D01275
nsc 123127
(1s,3s)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranoside hydrochloride
doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (hplc)
HMS1569G18
sr-01000003049
SR-01000003049-10
KUC110341C
ksc-230-184-1
AKOS007930231
dtxcid1010636
tox21_112061
NCGC00260032-01
tox21_202483
dtxsid3030636 ,
A817779
resmycin
BCP9000237
dsstox_rid_80678
NCGC00014486-01
dsstox_gsid_45111
dsstox_cid_10636
tox21_110050
AKOS015920241
CCG-100975
adrosal
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8s,10s)-
doxorubicin hydrochloride [usp:jan]
duxocin
unii-82f2g7bl4e
lipo-dox
82f2g7bl4e ,
HY-15142
doxorubicin (hydrochloride)
CS-1239
BCPP000429
S1208
doxorubicin hydrochloride [vandf]
doxorubicin hydrochloride [ep monograph]
doxorubicin hydrochloride [who-dd]
doxorubicin hydrochloride [ema epar]
doxorubicin hydrochloride [who-ip]
doxorubicini hydrochloridum [who-ip latin]
(8s,10s)-10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
doxorubicin hydrochloride liposome
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-.alpha.-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8s-cis)-
doxorubicin hydrochloride [mart.]
doxorubicin hydrochloride liposome [vandf]
doxorubicin hydrochloride [usp-rs]
doxorubicin hydrochloride [usp monograph]
liposomal doxorubicin hydrochloride [who-dd]
imx-110 component doxorubicin hydrochloride
doxorubicin hydrochloride [orange book]
adriamycin [iarc]
NC00225
SCHEMBL3242
NCGC00263918-03
tox21_110050_1
(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
doxorubicin.hcl
MWWSFMDVAYGXBV-RUELKSSGSA-N
10-[(3-amino-2,3,6-trideoxy-?-l-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride
adriblastina hydrochloride
EX-A1337
doxorubicin (adriamycin) hcl
doxorubicin hydrochloride, united states pharmacopeia (usp) reference standard
doxorubicin hydrochloride, european pharmacopoeia (ep) reference standard
Z1557399790
EN300-123444
(8s-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
doxorubicin hydrochloride, pharmaceutical secondary standard; certified reference material
CHEBI:31522
SR-01000003049-5
(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen
(8s,10s)-10-((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
HB4183
10-[(3-amino-2,3,6-trideoxy-alpha-l-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride
adriamycin (doxorubicin hydrochloride
(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride
doxorubicin hydrochloride,(s)
Q27032359
AS-31687
2-chloro-4-fluorobenzenesulphonylchloride
(8s,10s)-10-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
BD164391
doxorubicin hydrochloride- bio-x
adriamycine
3-hydroxyacetyldaunorubicin hydrochloride
doxorubicin hydrochloride (usp-rs)
l-lyxo-hexopyranoside, 3b-glycol-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-, hydrochloride
adriamycin hcl
14-hydroxydaunorubicin hydrochloride
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8s-cis)-
adriamycin-hcl
doxorubin
doxorubicin hydrochloride (usp monograph)
doxil (liposomal)
adriamycin (iarc)
doxorubicin hydrochloride (ep monograph)
14'-hydroxydaunomycin
chloridrato de doxorrubicina
doxorubicin hydrochloride (usp:jan)
doxorubicin hydrochloride (mart.)
(2s,4s)-4-(3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride, (8s-cis)-

Drug Classes (2)

ClassDescription
folic acidsA group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid units.
anthracyclineAnthracyclines are polyketides that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (164)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency56.23410.631035.7641100.0000AID504339
acid sphingomyelinaseHomo sapiens (human)Potency25.118914.125424.061339.8107AID504937
glp-1 receptor, partialHomo sapiens (human)Potency35.48130.01846.806014.1254AID624417
thioredoxin reductaseRattus norvegicus (Norway rat)Potency25.11890.100020.879379.4328AID588456
ClpPBacillus subtilisPotency15.84891.995322.673039.8107AID651965
WRNHomo sapiens (human)Potency28.18380.168331.2583100.0000AID651768
TDP1 proteinHomo sapiens (human)Potency0.03950.000811.382244.6684AID686978; AID686979
67.9K proteinVaccinia virusPotency9.29960.00018.4406100.0000AID720579; AID720580
IDH1Homo sapiens (human)Potency0.23110.005210.865235.4813AID686970
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency2.49060.316212.443531.6228AID902; AID924
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.87450.00419.984825.9290AID504444; AID720524
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency5.01193.548119.542744.6684AID743266
importin subunit beta-1 isoform 1Homo sapiens (human)Potency112.20205.804836.130665.1308AID540263
snurportin-1Homo sapiens (human)Potency112.20205.804836.130665.1308AID540263
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency75.68630.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency7.94330.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
survival motor neuron protein isoform dHomo sapiens (human)Potency0.35480.125912.234435.4813AID1458
Integrin beta-3Homo sapiens (human)Potency3.98110.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency3.98110.316211.415731.6228AID924
TAR DNA-binding protein 43Homo sapiens (human)Potency15.84891.778316.208135.4813AID652104
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency9.83440.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency20.38650.004023.8416100.0000AID485290
Chain A, Breast cancer type 1 susceptibility proteinHomo sapiens (human)Potency10.00001.258920.440939.8107AID892
Chain A, Beta-lactamaseEscherichia coli K-12Potency31.62280.044717.8581100.0000AID485341
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency22.33420.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency7.07950.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency24.75660.125919.1169125.8920AID2549; AID2708
Chain A, Ferritin light chainEquus caballus (horse)Potency31.62285.623417.292931.6228AID485281
Chain A, CruzipainTrypanosoma cruziPotency28.18380.002014.677939.8107AID1478
LuciferasePhotinus pyralis (common eastern firefly)Potency25.56230.007215.758889.3584AID1224835; AID588342
interleukin 8Homo sapiens (human)Potency66.82420.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency17.47360.002541.796015,848.9004AID1347395; AID1347398
glp-1 receptor, partialHomo sapiens (human)Potency2.23870.01846.806014.1254AID624417
WRNHomo sapiens (human)Potency56.23410.168331.2583100.0000AID651768
phosphopantetheinyl transferaseBacillus subtilisPotency44.66840.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency10.16313.189029.884159.4836AID1224846; AID1224894
RAR-related orphan receptor gammaMus musculus (house mouse)Potency10.05670.006038.004119,952.5996AID1159521; AID1159523
ATAD5 protein, partialHomo sapiens (human)Potency2.31090.004110.890331.5287AID504467
Fumarate hydrataseHomo sapiens (human)Potency1.12200.00308.794948.0869AID1347053
USP1 protein, partialHomo sapiens (human)Potency31.62280.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency0.10410.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency0.28940.000714.592883.7951AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency14.14060.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency1.94460.000221.22318,912.5098AID1259243; AID1259247; AID588516; AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
thioredoxin glutathione reductaseSchistosoma mansoniPotency50.11870.100022.9075100.0000AID485364
signal transducer and activator of transcription 6, interleukin-4 inducedHomo sapiens (human)Potency3.98112.51199.410115.8489AID922; AID935
Smad3Homo sapiens (human)Potency1.33440.00527.809829.0929AID588855; AID720534; AID720536; AID720537
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency6.02920.013326.981070.7614AID1346978
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.93420.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency6.67460.00137.762544.6684AID2120; AID914; AID915
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency3.84660.000657.913322,387.1992AID1259377; AID1259378; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency0.46800.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency4.20940.000417.946075.1148AID1346784; AID1346795; AID1347036
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency6.14180.01237.983543.2770AID1346984; AID1645841
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency19.95260.28189.721235.4813AID2326
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.55660.000214.376460.0339AID588532; AID588533; AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency17.68930.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency2.95650.000817.505159.3239AID1159527; AID1159531; AID588544; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.43930.001530.607315,848.9004AID1224841; AID1224842; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency3.74030.375827.485161.6524AID588526; AID743217; AID743220; AID743239
pregnane X nuclear receptorHomo sapiens (human)Potency26.60320.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency6.52240.000229.305416,493.5996AID1259244; AID1259248; AID588513; AID743069; AID743075; AID743077; AID743078; AID743079; AID743080; AID743091
cytochrome P450 2D6Homo sapiens (human)Potency24.54540.00108.379861.1304AID1645840
polyproteinZika virusPotency1.12200.00308.794948.0869AID1347053
67.9K proteinVaccinia virusPotency14.97630.00018.4406100.0000AID720579; AID720580
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency35.48130.707936.904389.1251AID504333
P53Homo sapiens (human)Potency28.18380.07319.685831.6228AID504706
shiga toxin 1 variant A subunitEscherichia coli O157:H7Potency14.38065.035416.193232.6037AID2320; AID493123
shiga toxin 1 B subunitEscherichia coli O157:H7Potency20.57155.035413.848822.4921AID2320
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency7.47510.001024.504861.6448AID588535; AID743212; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency6.93200.001019.414170.9645AID588536; AID588537; AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency6.40650.023723.228263.5986AID588541; AID743222; AID743223
caspase-3Homo sapiens (human)Potency6.02920.013326.981070.7614AID1346978
IDH1Homo sapiens (human)Potency9.20000.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency22.38720.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency13.77470.000723.06741,258.9301AID651777; AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency4.20120.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency27.05500.001628.015177.1139AID1224843; AID1224895; AID1259385
activating transcription factor 6Homo sapiens (human)Potency6.88370.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency7.74970.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency8.00320.039147.5451146.8240AID1224845; AID1224896
Caspase-7Cricetulus griseus (Chinese hamster)Potency30.58550.006723.496068.5896AID1346980
Bloom syndrome protein isoform 1Homo sapiens (human)Potency34.47750.540617.639296.1227AID2528; AID2585
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency0.25120.01262.451825.0177AID485313
tumor necrosis factorHomo sapiens (human)Potency8.41270.375823.492842.1632AID651757
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency23.18100.010039.53711,122.0200AID1469; AID1479; AID588545; AID588547
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.36630.00419.984825.9290AID504444
transcriptional regulator ERG isoform 3Homo sapiens (human)Potency1.25890.794321.275750.1187AID624246
caspase-3Cricetulus griseus (Chinese hamster)Potency30.58550.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.58070.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency11.23710.037617.082361.1927AID1259364; AID1259388
heat shock protein beta-1Homo sapiens (human)Potency20.41460.042027.378961.6448AID743210
DNA polymerase betaHomo sapiens (human)Potency8.91250.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency20.38650.039816.784239.8107AID1454; AID995
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency44.66844.466824.832944.6684AID651749
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency10.00000.65619.452025.1189AID463254
ras-related protein Rab-9AHomo sapiens (human)Potency0.44670.00022.621531.4954AID485297
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency11.91730.168316.404067.0158AID720504
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency1.93650.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
DNA polymerase eta isoform 1Homo sapiens (human)Potency44.66840.100028.9256213.3130AID588591
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency3.78810.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency0.79430.004611.374133.4983AID624297
DNA polymerase kappa isoform 1Homo sapiens (human)Potency2.81840.031622.3146100.0000AID588579
survival motor neuron protein isoform dHomo sapiens (human)Potency0.69630.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency5.62340.00419.962528.1838AID2675
neuropeptide S receptor isoform AHomo sapiens (human)Potency0.63100.015812.3113615.5000AID1461
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency1.98720.001557.789015,848.9004AID1259244
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency100.00006.309660.2008112.2020AID720707
Interferon betaHomo sapiens (human)Potency23.57030.00339.158239.8107AID1347407
Cellular tumor antigen p53Homo sapiens (human)Potency0.82990.002319.595674.0614AID651631; AID651743; AID720552
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency1.98720.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Platelet-activating factor receptorHomo sapiens (human)Potency10.000010.000025.781039.8107AID892
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Alpha-synucleinHomo sapiens (human)Potency4.46680.56239.398525.1189AID652106
Nuclear receptor ROR-gammaHomo sapiens (human)Potency1.05910.026622.448266.8242AID651802
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency21.15461.000010.475628.1838AID1457
TAR DNA-binding protein 43Homo sapiens (human)Potency35.48131.778316.208135.4813AID652104
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency11.22023.981146.7448112.2020AID720708
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency0.30200.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency0.27390.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency37.93300.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
polyadenylate-binding protein 1Homo sapiens (human)IC50 (µMol)46.85004.910023.702976.1900AID602259; AID602260
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)IC50 (µMol)35.88801.15306.28039.9630AID602168; AID602235
transactivating tegument protein VP16 [Human herpesvirus 1]Human alphaherpesvirus 1 (Herpes simplex virus type 1)IC50 (µMol)35.88800.94604.70169.4870AID602167; AID602236
VifHuman immunodeficiency virus 1IC50 (µMol)49.18000.270034.0015100.0000AID1117319
TatHuman immunodeficiency virus 1IC50 (µMol)40.14100.996039.8009100.0000AID1117361
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)IC50 (µMol)49.18000.270026.3638100.0000AID1117319
nuclear receptor coactivator 3 isoform aHomo sapiens (human)IC50 (µMol)35.88800.14764.33099.9200AID602166; AID602234
Dihydrofolate reductaseHomo sapiens (human)IC50 (µMol)0.03000.00060.87267.3000AID1892323
Bifunctional dihydrofolate reductase-thymidylate synthaseLeishmania majorIC50 (µMol)0.03000.03000.03000.0300AID1892322
Pteridine reductase 1Leishmania majorIC50 (µMol)2.95002.95002.95002.9500AID1892320
Pteridine reductase, putative Trypanosoma brucei brucei TREU927IC50 (µMol)0.05000.05000.05000.0500AID1892319
Bifunctional dihydrofolate reductase-thymidylate synthaseTrypanosoma brucei brucei TREU927IC50 (µMol)0.01000.01000.01000.0100AID1892321
RNA polymerase beta subunit (EC 2.7.7.6), partialEscherichia coliIC50 (µMol)14.374711.687217.090023.7759AID826
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)IC50 (µMol)15.13300.17369.803229.2701AID712; AID754
Apoptotic peptidase activating factor 1Homo sapiens (human)IC50 (µMol)60.60000.037518.623253.2000AID588524; AID588538
RAD51Homo sapiens (human)IC50 (µMol)85.00001.399017.721432.1000AID1435
TPA: protein transporter TIM23Saccharomyces cerevisiae S288CIC50 (µMol)12.70000.880010.503632.9000AID493002
caspase-9 isoform alpha precursorHomo sapiens (human)IC50 (µMol)34.60000.025616.507052.8000AID588574
caspase-3 isoform a preproproteinHomo sapiens (human)IC50 (µMol)34.60000.025620.323574.3000AID588574
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)IC50 (µMol)15.13300.17369.803229.2701AID712; AID754
14-3-3 protein gammaHomo sapiens (human)IC50 (µMol)0.78120.78120.78120.7812AID711
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)96.91000.00022.318510.0000AID1486951
DNA topoisomerase 2-alphaHomo sapiens (human)IC50 (µMol)0.94000.48004.35649.9400AID1663790
putative polyproteinIC50 (µMol)90.72050.25083.82838.4620AID720577; AID720578
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
streptokinase A precursorStreptococcus pyogenes M1 GASEC50 (µMol)1.14900.06008.9128130.5170AID1902
ORF73Human gammaherpesvirus 8EC50 (µMol)7.69000.06008.134632.1400AID435023
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
aryl hydrocarbon receptor nuclear translocatorHomo sapiens (human)AC5074.49000.190023.3694115.5100AID651703
LANAHuman gammaherpesvirus 8AC500.62900.042032.4569312.0010AID504726
transforming acidic coiled-coil-containing protein 3Homo sapiens (human)AC5074.49000.190024.2333115.5100AID651703
PAX8Homo sapiens (human)AC505.46000.04885.435469.1700AID687027
Skn7pSaccharomyces cerevisiae (brewer's yeast)AbsAC40_uM6.21000.66005.269618.2300AID624258
LANAHuman gammaherpesvirus 8AC502.74530.042032.4569312.0010AID504725; AID504726; AID504727
S100A4, partialHomo sapiens (human)AC500.32300.23501.76286.0200AID687001
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)AC5043.41001.67009.266943.4100AID588683
UDP-galactopyranose mutaseMycobacterium tuberculosis H37RvAC5032.18006.860045.866798.5600AID540359
kelch-like ECH-associated protein 1Homo sapiens (human)AC5043.41001.67009.266943.4100AID588683
HSP40, subfamily A [Plasmodium falciparum 3D7]Plasmodium falciparum 3D7AbsAC1000_uM6.47900.12904.116911.3160AID540271
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (413)

Processvia Protein(s)Taxonomy
tetrahydrobiopterin biosynthetic processDihydrofolate reductaseHomo sapiens (human)
one-carbon metabolic processDihydrofolate reductaseHomo sapiens (human)
negative regulation of translationDihydrofolate reductaseHomo sapiens (human)
axon regenerationDihydrofolate reductaseHomo sapiens (human)
response to methotrexateDihydrofolate reductaseHomo sapiens (human)
dihydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate biosynthetic processDihydrofolate reductaseHomo sapiens (human)
folic acid metabolic processDihydrofolate reductaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityDihydrofolate reductaseHomo sapiens (human)
regulation of removal of superoxide radicalsDihydrofolate reductaseHomo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
hematopoietic progenitor cell differentiationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-alphaHomo sapiens (human)
DNA ligationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA damage responseDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome segregationDNA topoisomerase 2-alphaHomo sapiens (human)
female meiotic nuclear divisionDNA topoisomerase 2-alphaHomo sapiens (human)
apoptotic chromosome condensationDNA topoisomerase 2-alphaHomo sapiens (human)
embryonic cleavageDNA topoisomerase 2-alphaHomo sapiens (human)
regulation of circadian rhythmDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of apoptotic processDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDNA topoisomerase 2-alphaHomo sapiens (human)
rhythmic processDNA topoisomerase 2-alphaHomo sapiens (human)
negative regulation of DNA duplex unwindingDNA topoisomerase 2-alphaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-alphaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of cellular extravasationPlatelet-activating factor receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIPlatelet-activating factor receptorHomo sapiens (human)
chemotaxisPlatelet-activating factor receptorHomo sapiens (human)
inflammatory responsePlatelet-activating factor receptorHomo sapiens (human)
immune responsePlatelet-activating factor receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
parturitionPlatelet-activating factor receptorHomo sapiens (human)
response to symbiotic bacteriumPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of interleukin-6 productionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of tumor necrosis factor productionPlatelet-activating factor receptorHomo sapiens (human)
inositol trisphosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of neutrophil degranulationPlatelet-activating factor receptorHomo sapiens (human)
transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of translationPlatelet-activating factor receptorHomo sapiens (human)
negative regulation of blood pressurePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processPlatelet-activating factor receptorHomo sapiens (human)
cellular response to gravityPlatelet-activating factor receptorHomo sapiens (human)
cellular response to cAMPPlatelet-activating factor receptorHomo sapiens (human)
cellular response to fatty acidPlatelet-activating factor receptorHomo sapiens (human)
response to dexamethasonePlatelet-activating factor receptorHomo sapiens (human)
positive regulation of leukocyte tethering or rollingPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of transcytosisPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of maternal process involved in parturitionPlatelet-activating factor receptorHomo sapiens (human)
positive regulation of gastro-intestinal system smooth muscle contractionPlatelet-activating factor receptorHomo sapiens (human)
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholinePlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayPlatelet-activating factor receptorHomo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (120)

Processvia Protein(s)Taxonomy
mRNA regulatory element binding translation repressor activityDihydrofolate reductaseHomo sapiens (human)
mRNA bindingDihydrofolate reductaseHomo sapiens (human)
dihydrofolate reductase activityDihydrofolate reductaseHomo sapiens (human)
folic acid bindingDihydrofolate reductaseHomo sapiens (human)
NADPH bindingDihydrofolate reductaseHomo sapiens (human)
sequence-specific mRNA bindingDihydrofolate reductaseHomo sapiens (human)
NADP bindingDihydrofolate reductaseHomo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
magnesium ion bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
RNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-alphaHomo sapiens (human)
protein kinase C bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP-dependent activity, acting on DNADNA topoisomerase 2-alphaHomo sapiens (human)
DNA binding, bendingDNA topoisomerase 2-alphaHomo sapiens (human)
protein homodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
ubiquitin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein heterodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
lipopolysaccharide bindingPlatelet-activating factor receptorHomo sapiens (human)
lipopolysaccharide immune receptor activityPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled receptor activityPlatelet-activating factor receptorHomo sapiens (human)
platelet activating factor receptor activityPlatelet-activating factor receptorHomo sapiens (human)
protein bindingPlatelet-activating factor receptorHomo sapiens (human)
phospholipid bindingPlatelet-activating factor receptorHomo sapiens (human)
mitogen-activated protein kinase bindingPlatelet-activating factor receptorHomo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityPlatelet-activating factor receptorHomo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (85)

Processvia Protein(s)Taxonomy
mitochondrionDihydrofolate reductaseHomo sapiens (human)
cytosolDihydrofolate reductaseHomo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
centrioleDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome, centromeric regionDNA topoisomerase 2-alphaHomo sapiens (human)
condensed chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
male germ cell nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
cytoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA topoisomerase 2-alphaHomo sapiens (human)
protein-containing complexDNA topoisomerase 2-alphaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
plasma membranePlatelet-activating factor receptorHomo sapiens (human)
membranePlatelet-activating factor receptorHomo sapiens (human)
secretory granule membranePlatelet-activating factor receptorHomo sapiens (human)
tertiary granule membranePlatelet-activating factor receptorHomo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1266)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1892320Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892326Selectivity index, ratio of IC50 for human DHFR to IC50 for Trypanosoma brucei DHFR2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892321Inhibition of recombinant Trypanosoma brucei DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892325Selectivity index, ratio of IC50 for human DHFR to IC50 for Leishmania major PTR12022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892324Selectivity index, ratio of IC50 for human DHFR to IC50 for Trypanosoma brucei PTR12022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892319Inhibition of recombinant Trypanosoma brucei PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892323Inhibition of recombinant human DHFR expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892322Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID1892327Selectivity index, ratio of IC50 for human DHFR to IC50 for Leishmania major DHFR2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1347152Confirmatory screen NINDS AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347168HepG2 cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347153Confirmatory screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347167Vero cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID493017Wombat Data for BeliefDocking1996Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13
Synthesis and biological evaluation of N alpha-(4-amino-4-deoxy-10-methylpteroyl)-DL-4,4-difluoroornithine.
AID493017Wombat Data for BeliefDocking2000Journal of medicinal chemistry, Oct-19, Volume: 43, Issue:21
Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID334276Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID1404434Cytotoxicity against human HepG2 cells assessed as decrease in cell viability by MTT assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Penicilindoles A-C, Cytotoxic Indole Diterpenes from the Mangrove-Derived Fungus Eupenicillium sp. HJ002.
AID1637318Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 2 days by MTT assay2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1236896Cytotoxicity against human DU145 cells incubated from day 2 to day 4 by CCK8 assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
AID1882814Anticancer activity against human A549 cells2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1762256Cytotoxicity against human AG01523 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
AID456254Cytotoxicity against human K562 cells after 4 days by ELISA reader assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
AID462322Cytotoxicity against human MCF7 cells in presence of 10% fetal bovine serum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
AID1875129Growth inhibition of human HCT-15 cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID1505073Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID1401030Antiproliferative activity against human MCF7/ADR cells after 96 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
AID1424263Antitumor activity against mouse S180 cells implanted in ICR mouse assessed as inhibition of tumor growth at 0.1 umol/kg, ip for 7 consecutive days starting 24 hrs after tumor cell inoculation relative to untreated control2017European journal of medicinal chemistry, Dec-15, Volume: 142Recent insights into synthetic β-carbolines with anti-cancer activities.
AID461178Antitumor activity against human K562 cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1168524Toxicity in mouse S180 cells allografted mouse assessed as heart weight at 1 umol/kg, ip for 7 consecutive days measured 24 hrs after last dose (Rvb = 0.12 +/- 0.02 g)2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID452681Cytotoxicity against human MCF7 cells after 3 days2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
AID1308396Inhibition of human topoisomerase 2-mediated DNA cleavage at 5 uM using supercoiled pHOT1 plasmid as substrate by agarose gel electrophoresis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1486763Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.
AID1566579Cytotoxicity against human PC3 cells2019European journal of medicinal chemistry, Sep-01, Volume: 177Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
AID592928Cytotoxicity against human A2780 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1441894Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
AID1355287Cytotoxicity against human HCT15 cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID1132920Cardiotoxicity in rat EEG model1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID478258Cytotoxicity against human vinblastine-resistant KBV1 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID548272Cytotoxicity against african green monkey COS1 cells assessed as reduction in cell viability after 32 hrs by luminescent assay2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.
AID1176797Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Feb-01, Volume: 25, Issue:3
Development of constrained tamoxifen mimics and their antiproliferative properties against breast cancer cells.
AID1888035Antiproliferative activity against human T47D cells after 72 hrs by EZ-Cytox colorimetric assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.
AID1437494Cytotoxicity against human WI38 cells after 72 hrs by CCK8 assay2017Journal of natural products, 01-27, Volume: 80, Issue:1
Nanomolar Antimalarial Agents against Chloroquine-Resistant Plasmodium falciparum from Medicinal Plants and Their Structure-Activity Relationships.
AID1337586Antiproliferative activity against human T47D cells measured after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
AID1668783Cytotoxicity against human A549 cells incubated for 48 hrs by MTT assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cytotoxic Heptaketides from the Endolichenic Fungus
AID376375Antitumor activity against human HT-29 cells1999Journal of natural products, Nov, Volume: 62, Issue:11
Synthesis of 11,12-epoxydrim-8,12-en-11-ol, 11,12-diacetoxydrimane, and warburganal from (-)-sclareol.
AID490208Cytotoxicity against human 22Rv1 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1776430Cytotoxicity against human A549 cells assessed as cell viability inhibition for 48 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Diverse Prenylated Bibenzyl Enantiomers from the Chinese Liverwort
AID619820Cytotoxicity against human HepG2 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1185779Growth inhibition of human MGC803 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1436222Cytotoxicity against human HeLa cells assessed as cell growth at 10'-5 M after 48 hrs by SRB assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
AID1145594Antiproliferative activity against MEF after 72 hrs1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.
AID249857Percent control of human mammary adenocarcinoma MCF-7 cell line proliferation at 0.3 ng/mL2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
AID478017Antiproliferative activity against human K562/A02 cells after 72 hrs by sulforhodamine B assay2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
AID1486951Inhibition of ABCB1 in human K562/A02 cells assessed as potentiation of adriamycin-induced cytotoxicity by measuring ADR IC50 at 5 uM measured after 48 hrs by MTT assay (Rvb = 43.75 to 96.91 uM)2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
AID1337477Antiproliferative activity against HEK293 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1875133Growth inhibition of human PC-3 cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID673200Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2012Bioorganic & medicinal chemistry, Aug-01, Volume: 20, Issue:15
Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
AID8998Cytotoxicity against A-549 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID1783253Cytotoxicity against human A549 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID1762255Cytotoxicity against human PC-3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
AID1612623Antiproliferative activity against human VCR-resistant K562/VCR cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID734086Growth inhibition against human IGROV cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID512047Cytotoxicity against human PC3 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1356000Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID619817Cytotoxicity against human KB cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1869701Cytotoxicity against human PC-3 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay2022Journal of natural products, 07-22, Volume: 85, Issue:7
Suncheonosides E-M and Benzothioate Derivatives from the Marine-Derived
AID461390Antitumor activity against human SK-MEL-5 cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1577579Antiproliferative activity against human T47D cells measured after 72 hrs by EZ-Cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID1459362Cytotoxicity against human A549 cells by MTT assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Bissubvilides A and B, Cembrane-Capnosane Heterodimers from the Soft Coral Sarcophyton subviride.
AID1359657Antiproliferative activity against human MCF7/ADR cells after 48 to 72 hrs by MTT assay2018European journal of medicinal chemistry, May-25, Volume: 152Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
AID1288093Cytotoxicity against human T47D cells after 48 hrs by CCK8 assay2016European journal of medicinal chemistry, May-04, Volume: 113A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.
AID1904126Cytotoxicity against human K562 cells after 48 hrs by MTT assay2022European journal of medicinal chemistry, Apr-05, Volume: 233Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
AID484748Cytotoxicity against human SiHa cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1331841Cytotoxicity against human MCF10A cells assessed as cell growth inhibition after 48 hrs by SRB assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Isolation of Coralmycins A and B, Potent Anti-Gram Negative Compounds from the Myxobacteria Corallococcus coralloides M23.
AID1875132Growth inhibition of human ACHN cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID592931Cytotoxicity against human SiHa cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1176796Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Feb-01, Volume: 25, Issue:3
Development of constrained tamoxifen mimics and their antiproliferative properties against breast cancer cells.
AID1583358Antiproliferative activity against human U118MG cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID1461759Cytotoxicity against human MCF7/ADR cells after 72 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1672166Cytotoxicity against human K562 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia.
AID1337474Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1525109Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Strepantibins A-C: Hexokinase II Inhibitors from a Mud Dauber Wasp Associated Streptomyces sp.
AID1439747Cytotoxicity against African green monkey Vero cells after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID1757281Resistant index, ratio of IC50 for ADR-resistant human Bel-7402 cells to IC50 for human Bel-7402 cells2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID1164702Cytotoxicity against human NCI-H1688 cells after 24 hrs by MTT assay2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Notolutesins A-J, dolabrane-type diterpenoids from the Chinese liverwort Notoscyphus lutescens.
AID1481512Resistance index, ratio of IC50 for human K562/A02 cells to IC50 for human K562 cells2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
AID1617191Cytotoxicity against human HCT15 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID1272242Cytotoxicity against human HeLa cells2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Efficiently functionalized oxacalix[4]arenes: Synthesis, characterization and exploration of their biological profile as novel HDAC inhibitors.
AID1264616Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID1904127Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay2022European journal of medicinal chemistry, Apr-05, Volume: 233Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
AID1428409Cytotoxicity against vinblastine-sensitive human MCF7 cells assessed as growth inhibition after 72 hrs by SRB assay
AID592933Cytotoxicity against human MCF7 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1684107Cytotoxicity against mouse p388 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1358352Cytotoxicity against human Aspc-1 cells after 72 hrs under hypoxic condition by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID512240Anticancer activity against human KB cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
AID592697Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID699783Growth inhibition of human SKBR3 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Synthesis and antimitotic and tubulin interaction profiles of novel pinacol derivatives of podophyllotoxins.
AID621709Binding affinity to human serum transferrin after 12 hrs at pH 4.8 by spectrofluorometer method2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID633825Cytotoxicity against human 647V cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1625414Cytotoxicity against human BGC823 cells assessed as reduction in cell viability by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.
AID1822516Cytotoxicity in human MCF7 assessed as inhibition in cell growth measured after 24 hrs by MTT assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
AID494502Inhibition of pig brain tubulin polymerization after 30 mins by turbidimetry2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety.
AID1400963Antiproliferative activity in human A549 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Aug-18, Volume: 136Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
AID1498376Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
AID1822520Drug resistance index, ratio of IC50 for human MCF7 cancer cell to ratio of IC50 for human NCI-ADR-RES cancer cell2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
AID1664702Growth inhibition of human HOP62 cells after 48 hrs by MTT assay2020Bioorganic & medicinal chemistry, 08-01, Volume: 28, Issue:15
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
AID1057307Growth inhibition of human MCF7 cells after 72 hrs by CellTiter-Blue assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
AID1188099Cytotoxicity against human THP1 cells assessed as growth inhibition at 1 uM after 48 hrs by sulforhodamine B assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies.
AID1461761Cytotoxicity against human wild-type MCF7 cells assessed as cell growth at 3 mM after 72 hrs relative to control2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1481761Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
AID1435304Dark toxicity against rat H9c2 cells at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1374095Antiproliferative activity against human HCT15 cells incubated for 72 hrs by CCK8 assay2018Bioorganic & medicinal chemistry letters, 02-15, Volume: 28, Issue:4
Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.
AID1612622Drug resistance index, ratio of IC50 for taxol-resistant human A549/TR cells to IC50 for human A549 cells2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1358349Cytotoxicity against human PANC1 cells after 72 hrs under normoxic condition by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1668785Cytotoxicity against human KB cells incubated for 48 hrs by MTT assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cytotoxic Heptaketides from the Endolichenic Fungus
AID1524006Therapeutic index, ratio of IC50 for mouse 3T3 cells to IC50 for mouse 4T1 cells2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
AID1849911Antitumor activity against Adriamycin-resistant human MCF7 cells xenografted in athymic nude BALB/c mouse assessed as tumor growth inhibition at 5 mg/kg, iv measured every 4 days for 40 days by caliper method relative to control2021European journal of medicinal chemistry, Jan-15, Volume: 210Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats.
AID592936Cytotoxicity against human PC3 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1524000Antiproliferative activity against mouse 4T1 cells measured after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
AID478255Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1612627Drug resistance index, ratio of IC50 for ADR-resistant human Bel7402/ADR cells to IC50 for human Bel7402 cells2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1759485Cytotoxicity against human Panel (12 tumour cell lines)2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Synthesis and anti-tumor activity of marine alkaloids.
AID1278418Cytotoxicity against human KG1a cells after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1783252Cytotoxicity against human Bel-7402 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID1671758Inhibition of TGF-beta1-induced cell invasion in human SMMC-7721 cells at 0.5 uM incubated for 2 days by crystal violet staining based matrigel transwell migration assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID549508Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.
AID1426446Inhibition of porcine tubulin polymerization after 45 mins by turbidometric method2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization.
AID1583360Antiproliferative activity against human SHG44 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID1762253Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
AID512161Cytotoxicity against human KB cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1594687Cytotoxicity in human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID1901894Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by CCK-8 assay2022Bioorganic & medicinal chemistry, 03-01, Volume: 57Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
AID1671736Antiproliferative activity against human NCI-H1299 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1202748Growth inhibition of human MG63 cells by MTT method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
1,19-seco-Avermectin analogues from a ΔaveCDE mutant Streptomyces avermectinius strain.
AID1441127Cytotoxicity against human DU145 cells assessed as decrease in cell viability up to 8 uM after 48 hrs in presence of pan-caspase inhibitor QVD-OPh by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1387377Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Dinghupeptins A-D, Chymotrypsin Inhibitory Cyclodepsipeptides Produced by a Soil-Derived Streptomyces.
AID1405497Therapeutic index, ratio of IC50 for human HPDE6c7 cells to IC50 for human PANC1 cells2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1905059Antiproliferative activity against human paclitaxel-resistant A2780/TAX cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1390169Antiproliferative activity against human T47D cells after 72 hrs by CCK-8 assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents.
AID1441111Cytotoxicity against human MDA-MB-231 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1358357Inhibition of cancer stem cell population of human PANC1 cells assessed as CD24+/CD44+/ESA+ cell population level at 0.15 uM after 48 hrs by flow cytometric analysis (Rvb = 1.7%)2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1478725Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity.
AID1880229Antiproliferative activity against human ASPC1 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay2022ACS medicinal chemistry letters, May-12, Volume: 13, Issue:5
Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.
AID1524520Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
AID619818Cytotoxicity against human BGC823 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1145597Antitumor activity against mouse Sarcoma 180 cells allografted in mouse assessed as average survival time at 2 mg/kg, ip on day 1 post challenge relative to untreated control1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.
AID1577630Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by Ez-cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID1174947Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, Dec-15, Volume: 22, Issue:24
Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.
AID1783254Cytotoxicity against human U251 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID1126888Cytotoxicity against mouse BALB/3T3 cells assessed as cell viability after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
AID1757279Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID1498576Growth inhibition of human MCF7 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID1057309Growth inhibition of human MDA-MB-231 cells after 72 hrs by CellTiter-Blue assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
AID1697198Cytotoxicity against human PC3 cells by colorimetric method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
AID1905058Antiproliferative activity against human vincristine-resistant HCT-8/VCR cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID551374Cytotoxicity against human HOP62 assessed as inhibition of cell growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
AID1401811Cytotoxicity against human HCT15 cells after 72 hrs by cell counting kit-8 analysis2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
AID85243In vitro cytotoxic activity against human squamous cell carcinoma (HSC-2) cells.1999Bioorganic & medicinal chemistry letters, Nov-01, Volume: 9, Issue:21
Alpha-trifluoromethylated acyloins induce apoptosis in human oral tumor cell lines.
AID1132915In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 2 mg/kg, ip administered on days 1 to 9 relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID549504Cytotoxicity against human PC3 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.
AID1664701Growth inhibition of human MCF7 cells after 48 hrs by MTT assay2020Bioorganic & medicinal chemistry, 08-01, Volume: 28, Issue:15
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
AID478018Antiproliferative activity against human KB/VCR cells after 72 hrs by sulforhodamine B assay2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
AID1459363Cytotoxicity against human HuH7 cells by CCK-8 assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Bissubvilides A and B, Cembrane-Capnosane Heterodimers from the Soft Coral Sarcophyton subviride.
AID1899072Resistant index, ratio IC50 for KB-V1 cells over IC50 for KB cells
AID1504777Cytotoxicity against human HT-29 cells by SRB assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Cephanolides A-J, Cephalotane-Type Diterpenoids from Cephalotaxus sinensis.
AID1887844Antiproliferative activity against adriamycin resistant human MCF7/ADR cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
AID636831Cytotoxicity against human KB cells by resazurin microplate assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Lanostane and hopane triterpenes from the entomopathogenic fungus Hypocrella sp. BCC 14524.
AID633824Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1288334Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
AID1882813Anticancer activity against mouse L1210 cells2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID478102Cytotoxicity against human NCI-H187 cells after 45 hrs by resazurin microplate assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Hopane-type triterpenes and binaphthopyrones from the scale insect pathogenic fungus Aschersonia paraphysata BCC 11964.
AID1657549Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
AID334277Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID170954Compound was evaluated for augmentation of rat liver microsomal oxygen consumption relative to doxorubicin1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1617194Cytotoxicity against human ACHN cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID1405489Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1664703Growth inhibition of human A549 cells after 48 hrs by MTT assay2020Bioorganic & medicinal chemistry, 08-01, Volume: 28, Issue:15
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
AID478303Induction of apoptosis in human HL60 cells assessed as appearance of intact mitochondria in cytosol at 5 uM after 6 hrs using JC1 dye relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1320987Cytotoxicity against docetaxel-resistant human PC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
AID1405491Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1713809Cytotoxicity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
AID1762050Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
AID566855Cytotoxicity against human HL60 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1583359Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID673199Antiproliferative activity against human MV4-11 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Aug-01, Volume: 20, Issue:15
Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
AID613196Antitumor activity against human MDA-MB-231 cells after 72 hrs by SRB assay2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment.
AID512026Cytotoxicity against human COLO205 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1145595Inhibition of Murine sarcoma virus (Moloney) foci formation in MEF after 72 hrs1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.
AID1890789Cytotoxicity against human PC-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID1637340Cytotoxicity against human MCF7 cells assessed as cell viability at 5 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID478251Cytotoxicity against human 518A2 cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1505074Cytotoxicity against human MCF7/ADR cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID592420Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Trigonosins A-F, daphnane diterpenoids from Trigonostemon thyrsoideum.
AID1426654Anti-proliferative activity against human K562 cells measured after 72 hrs by MTS assay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1337478Antiproliferative activity against HFL1 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1423929Cytotoxicity against human SMMC7721 cells assessed as inhibition of growth incubated for 72 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
AID1879217Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell proliferation2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships.
AID512055Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1227994Cytotoxic activity against human H460 cells by MTT method2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.
AID1172774Anti-proliferative activity against human NUGC3 cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1337472Inhibition of human DNA topoisomerase-2alpha at 20 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1869703Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay2022Journal of natural products, 07-22, Volume: 85, Issue:7
Suncheonosides E-M and Benzothioate Derivatives from the Marine-Derived
AID1706712Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1387378Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Dinghupeptins A-D, Chymotrypsin Inhibitory Cyclodepsipeptides Produced by a Soil-Derived Streptomyces.
AID1227998Cytotoxic activity against human HeLa cells by MTT method2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.
AID1441113Cytotoxicity against human JIMT1 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID138191Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 2 mg/kg1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1822517Cytotoxicity in human NCI-ADR-RES assessed as inhibition in cell growth measured after 24 hrs by MTT assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
AID1281586Selectivity index, ratio of IC50 for HAF to IC50 for human T47D cells2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
AID1185517Cytotoxicity against human T47D cells after 4 days by CCK-8 assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
AID1821802Antiproliferative activity against human MCF-10A cells assessed as reduction in cell viability after 48 hrs by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1612610Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID569516Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
AID1168509Cytotoxicity against human A549 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1168525Toxicity in mouse S180 cells allografted mouse assessed as liver weight at 1 umol/kg, ip for 7 consecutive days measured 24 hrs after last dose (Rvb = 1.84 +/- 0.32 g)2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1402296Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID689427Cytotoxicity against human A549 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
AID1421552Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID734089Growth inhibition against human PANC1 cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID595893Cytotoxicity against human MCF7 cells after 45 hrs by resazurin microplate assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive compounds from the scale insect pathogenic fungus Conoideocrella tenuis BCC 18627.
AID1381566Cytotoxicity against human A549 cells by SRB assay
AID1566577Cytotoxicity against human MGC803 cells2019European journal of medicinal chemistry, Sep-01, Volume: 177Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
AID1498579Growth inhibition of human MDA-MB-231 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID404063Cytotoxicity against human HT1080 cells after 24 hrs by MTT assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Chemical constituents of Brazilian propolis and their cytotoxic activities.
AID1899071Antiproliferative activity against human KB-V1 cells measured after 72 hrs by SRB assay
AID1277894Cytotoxicity against human QG56 cells assessed as cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives.
AID478271Induction of apoptosis in human HL60 cells assessed as increase of caspase 3 activity at 5 uM after 12 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1308434Induction of intracellular ROS accumulation in human U2OS/DX100 cells at 5 uM incubated for 24 hrs by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1355999Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID1625735Cytotoxicity against beta-tubulin 3 overexpressing human A2780T cells assessed as reduction in cell growth after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1330742Cytotoxicity against human T47D cells assessed as reduction in cell growth after 72 hrs by CCK8 assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
AID1505075Cytotoxicity against human A549 cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID480111Cytotoxicity against human HL60 cells after 2 days by automatic ELISA reader system2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
AID1337469Inhibition of human DNA topoisomerase-1 at 100 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1490964Cytotoxicity against human MCF7/ADM cells after 24 hrs by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1378629Antifungal activity against Fusarium verticillioides after 8 hrs by conidial germination assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1867123Cytotoxicity against human PANC-1 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
AID1498375Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
AID1489124Cytotoxicity against human BGC823 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID569480Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
AID1481489Cytotoxicity against human K562 cells after 48 hrs by MTT assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
AID478012Antiproliferative activity against human K562 cells after 72 hrs by sulforhodamine B assay2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
AID1287952Cytotoxicity against human T47D cells after 3 days by CCK8 assay2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.
AID1430412Cytotoxicity against human HeLa cells assessed as cell growth at 10'-6 M after 48 hrs by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
AID122235Antitumor activity against mice bearing P388 leukemia implanted ip on day 0, after treatment with three po doses on day 1,5,9 when the tumor had become systemic; Inactive1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID478269Induction of apoptosis in human HL60 cells assessed as DNA ladder formation at 5 uM after 24 hrs by agarose gel electrophoresis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1402297Antiproliferative activity against human SMMC7721 cells assessed as inhibition of cell proliferation at 25 uM after 72 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID1421547Antiproliferative activity against human A549 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID122232Antitumor activity against mice bearing B16 melanoma implanted ip on day 0, after treatment with three ip doses 10 mg/kg on day 1,5,9 when tumor had become systemic.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1638223Cytotoxicity against human Bel7402/5-FU cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1663788Anticancer activity against human A549 cells assessed as inhibition of cell proliferation2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Synthesis and evaluation of novel sulfonamide analogues of 6/7-aminoflavones as anticancer agents via topoisomerase II inhibition.
AID398901Cytotoxicity against human A549 cells1997Journal of natural products, Jun, Volume: 60, Issue:6
Cytotoxic and antiplatelet aggregation principles from Aglaia elliptifolia.
AID478308Cytotoxicity against human HL60 cells assessed as increase in ROS production at 5 uM after 72 hrs by NBT reduction assay relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID510624Cytotoxicity against human MDA-MB-231 cells after 4 days by MTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
AID1166322Cytotoxicity against human A549 cells after 48 hrs by SRB assay2014European journal of medicinal chemistry, Nov-24, Volume: 87β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents.
AID734495Growth inhibition against human LoVo/DX cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID1281585Cytotoxicity against HAF assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
AID1882749Anticancer activity against human MGC-803 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID478250Cytotoxicity against human 518A2 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1901895Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by CCK-8 assay2022Bioorganic & medicinal chemistry, 03-01, Volume: 57Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
AID1907347Antiproliferative activity against human NCI-ADR-RES cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID1757282Antiproliferative activity against taxol-resistant human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID1356001Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID456251Cytotoxicity against human MCF7 cells after 4 days by ELISA reader assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
AID480109Cytotoxicity against human DU145 cells after 2 days by automatic ELISA reader system2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
AID1481835Antiproliferative activity against human K562/ADR cells after 72 hrs by MTT assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
AID1671763Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as decrease in TGF-beta1-induced vimentin expression at 0.5 uM incubated for 48 hrs by immunofluorescence staining based laser-scanning confocal microscope2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1355289Cytotoxicity against human NCI-H23 cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID510628Cytotoxicity against human HeLa cells after 4 days by MTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
AID1401028Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
AID478260Cytotoxicity against human topotecan-resistant MCF7 cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1887104Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability by SRB assay
AID55638Change in thermal denaturation temperature of calf thymus DNA1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1430414Cytotoxicity against human HeLa cells assessed as cell growth at 10'-4 M after 48 hrs by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
AID461179Antitumor activity against human MOLT4F cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1699971Resistance index, ratio of of IC50 for human K562/A02 cells to IC50 for human K562 cells2020Bioorganic & medicinal chemistry letters, 12-15, Volume: 30, Issue:24
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
AID1524521Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
AID1699970Antiproliferative activity against human K562/A02 cells overexpressing P-gp by MTT assay2020Bioorganic & medicinal chemistry letters, 12-15, Volume: 30, Issue:24
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
AID478254Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1671762Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as increase in TGF-beta1 reduced E-cadherin expression at 0.5 uM incubated for 48 hrs by Immunofluorescence staining based laser-scanning confocal microscope2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1625417Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.
AID423397Cytotoxicity against human K562 cells after 48 hrs by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Bioactive alkaloids from endophytic Aspergillus fumigatus.
AID1426697Toxicity in BALB/c nude mouse administered via ip for every 3 days of four injections2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1617193Cytotoxicity against human NCI-H23 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID1185751Cytotoxicity against human MOLT4 cells after 48 hrs by Alamar blue assay2014European journal of medicinal chemistry, 09-12, Volume: 84Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
AID1400964Antiproliferative activity in human MCF7 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Aug-18, Volume: 136Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
AID512238Anticancer activity against human ZR-75-1 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
AID1435316Binding affinity to calf thymus duplex DNA by fluorescence spectroscopic method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1887847Resistance index, ratio of IC50 for antiproliferative activity against adriamycin resistant human MCF7/ADR cells to IC50 for antiproliferative activity against human MCF7 cells2022European journal of medicinal chemistry, Jan-05, Volume: 227Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
AID512019Cytotoxicity against human HOP62 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1132918In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.25 mg/kg, ip administered on days 1 to 9 relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1308402Cytotoxicity in human U2OS/DX30 cells at 5 uM incubated for 24 hrs by LDH release-based spectrofluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1671737Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1762049Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
AID478103Cytotoxicity against human MCF7 cells after 45 hrs by resazurin microplate assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Hopane-type triterpenes and binaphthopyrones from the scale insect pathogenic fungus Aschersonia paraphysata BCC 11964.
AID1168505Cytotoxicity against human HepG2 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1517673Antiproliferative activity against human Bel7402 incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
AID1612617Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID619897Cytotoxicity against human OS-RC2 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1625739Cytotoxicity against P-gp overexpressing human MCF7/ADR cells assessed as reduction in cell growth after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1327572Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2016Journal of natural products, 08-26, Volume: 79, Issue:8
Rhizovarins A-F, Indole-Diterpenes from the Mangrove-Derived Endophytic Fungus Mucor irregularis QEN-189.
AID1441125Cytotoxicity against cancer stem cells derived from human BT474 cells assessed as cancer stem cell death at 20 uM after 3 days by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1185753Cytotoxicity against human KG1 cells after 48 hrs by Alamar blue assay2014European journal of medicinal chemistry, 09-12, Volume: 84Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
AID1441129Cytotoxicity against human JIMT1 cells assessed as decrease in cell viability up to 8 uM after 48 hrs in absence of pan-caspase inhibitor QVD-OPh by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1625726Antiproliferative activity against human A2780S cells after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID462327Cytotoxicity against human HeLa cells in presence of 10% fetal bovine serum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
AID1657548Cytotoxicity against human A549 cells after 72 hrs by MTT assay
AID97978Dose required to inhibit the DNA synthesis in leukemia L1210 cells1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1890792Cytotoxicity against human HCT-15 cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID1358360Inhibition of ALDH in human PANC1 cells assessed as aldefluor positive cells at 0.5 uM after 72 hrs in presence of DEAB by aldefluor assay (Rvb = 0.455%)2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID592929Cytotoxicity against human HOP62 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1817884Antiproliferative activity against human HCT-15 cells assessed as reduction in cell viability after 48 hrs by by Ez-cytoX based microplate reader method2021European journal of medicinal chemistry, Dec-15, Volume: 226Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.
AID1612618Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1489123Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID621713Antiproliferative activity against human A549 cells by MTT assay in presence of human serum transferrin/apo transferrin2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID1486764Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.
AID734088Growth inhibition against human K562 cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID1435305Cytotoxicity against 7 mW/cm'2 irradiated human M14 cells assessed as increase in LDH release at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1331840Cytotoxicity against human MRC9 cells assessed as cell growth inhibition after 48 hrs by SRB assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Isolation of Coralmycins A and B, Potent Anti-Gram Negative Compounds from the Myxobacteria Corallococcus coralloides M23.
AID1882748Anticancer activity against human SGC-7901 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1308417Drug uptake in human U2OS/DX580 cells at 5 uM incubated for 24 hrs by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1612624Drug resistance index, ratio of IC50 for VCR-resistant human K562/VCR cells to IC50 for human K562 cells2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1525110Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Strepantibins A-C: Hexokinase II Inhibitors from a Mud Dauber Wasp Associated Streptomyces sp.
AID1541625Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Glucoconjugated Monoterpene Indole Alkaloids from
AID122110Antitumor activity against mice baering P388 leukemia (10e6 cells) implanted ip on day 0, after treatment with three ip doses (8 mg/kg) on day 5,9,13 when tumor became systemic.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1508149Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1430415Growth inhibition of human HeLa cells after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
AID1583362Antiproliferative activity against rat C6 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID1594720Cytotoxicity against human A549 cells measured after 72 hrs by CCK8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Cytotoxic Tigliane Diterpenoids from Croton damayeshu.
AID1508154Cell cycle arrest in human MCF7 cells assessed as accumulation at G0/G1 phase at 2 uM after 24 hrs by flow cytometric analysis (Rvb = 18.4%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID613198Antitumor activity against human A549 cells after 72 hrs by SRB assay2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment.
AID1546807Cytotoxicity against human A549 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1821807Selectivity index, ratio of IC50 for antiproliferative activity against human MCF-10A cells to IC50 for antiproliferative activity against human MDA-MB-231 cells by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1132914In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 4 mg/kg, ip administered on days 1 to 9 relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1684108Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1435966Cytotoxicity against human HepG2 cells assessed as growth inhibition at 10 uM measured after 72 hrs by CCK-8 assay relative to control
AID650185Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID1337473Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1498580Growth inhibition of human MDA-MB-231/ADR cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID1672167Cytotoxicity against human HL60 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia.
AID480110Cytotoxicity against human HCT15 cells after 2 days by automatic ELISA reader system2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
AID595892Cytotoxicity against human KB cells after 45 hrs by resazurin microplate assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive compounds from the scale insect pathogenic fungus Conoideocrella tenuis BCC 18627.
AID1821803Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1428411Cytotoxicity against multidrug resistant human MCF7 cells cultured in vinblastine containing medium assessed as growth inhibition after 72 hrs by SRB assay
AID1505072Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID1880231Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay2022ACS medicinal chemistry letters, May-12, Volume: 13, Issue:5
Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.
AID1288333Antiproliferative activity against human BT474 cells after 72 hrs by CCK8 assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
AID1185514Cytotoxicity against HEK293 cells after 4 days by CCK-8 assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
AID1288621Cytotoxicity against human K562/A02 cells assessed as cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
AID246830In vitro cytotoxicity against Leukemia L1210 cell line2005Bioorganic & medicinal chemistry letters, Aug-01, Volume: 15, Issue:15
A macromolecular prodrug of doxorubicin conjugated to a biodegradable cyclotriphosphazene bearing a tetrapeptide.
AID490287Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID621710Binding affinity to human apo transferrin after 12 hrs at pH 7.4 by spectrofluorometer method2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID613197Antitumor activity against human HT-29 cells after 72 hrs by SRB assay2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment.
AID1278414Cytotoxicity against human K562 cells after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1583361Antiproliferative activity against human U251 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID462328Cytotoxicity against human DU145 cells in presence of 10% fetal bovine serum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
AID1264615Cytotoxicity against human NCI-H1975 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID494501Antiproliferative activity against human K562 cells after 48 hrs2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety.
AID1888032Antiproliferative activity against human DU-145 cells after 72 hrs by EZ-Cytox colorimetric assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.
AID1768121Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 07-23, Volume: 84, Issue:7
Iridoid Constituents of
AID1901893Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by CCK-8 assay2022Bioorganic & medicinal chemistry, 03-01, Volume: 57Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
AID1783251Cytotoxicity against human HepG2 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID549507Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.
AID461391Antitumor activity against human NCI-H322 cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1491056Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Inflammation Modulatory Phorbol Esters from the Seeds of Aquilaria malaccensis.
AID1905057Resistance index, ratio of IC50 for antiproliferative activity against human adriamycin-resistant A549/ADR cells to IC50 for antiproliferative activity against human A549 cells2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1490961Cytotoxicity against human A549 cells after 24 hrs by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1318676Cytotoxicity against human MCF7 cells assessed as inhibition of cell survival rate after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121neo-Clerodane diterpenoids from Scutellaria barbata mediated inhibition of P-glycoprotein in MCF-7/ADR cells.
AID1320986Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
AID592699Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B based ELISA2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
AID1625740Resistance index, ratio of IC50 for P-gp overexpressing human MCF7/ADR cells to IC50 for human MCF7 cells2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1390168Antiproliferative activity against human HCT15 cells after 72 hrs by CCK-8 assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents.
AID592421Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Trigonosins A-F, daphnane diterpenoids from Trigonostemon thyrsoideum.
AID490207Cytotoxicity against human OS-RC2 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1278415Cytotoxicity against human K562/A02 cells after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1126868Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
AID1594689Cytotoxicity in human U251 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID478307Cytotoxicity against human HL60 cells assessed as increase in ROS production at 5 uM after 24 hrs by NBT reduction assay relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1546803Cytotoxicity against human L02 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1543248Cytotoxicity in human SW620 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID456252Cytotoxicity against human DU145 cells after 4 days by ELISA reader assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
AID619819Cytotoxicity against human 786-0 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1491062Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Inflammation Modulatory Phorbol Esters from the Seeds of Aquilaria malaccensis.
AID1075858Cytotoxicity against mouse B16F10 cells assessed as growth inhibition by SRB assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and IIα by its cytotoxic β-carboline alkaloids.
AID1478726Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity.
AID1421551Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID103703Cytotoxicity against MCF-7 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID138192Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 4 mg/kg1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID618833Cytotoxicity against human HeLa cells after 2 days by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
AID1489127Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID1326553Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Discovery and development of natural product oridonin-inspired anticancer agents.
AID1882809Anticancer activity against mouse L1210 cells assessed as reduction in cell viability for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1577566Antiproliferative activity against human NCI-H226 cells assessed as reduction in cell viability after 24 hrs by CCK8 assay
AID1611345Binding affinity to human serum albumin assessed as binding constant after 24 hrs by absorption spectroscopy2019Bioorganic & medicinal chemistry, 12-15, Volume: 27, Issue:24
Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]
AID1462353Cytotoxicity against African green monkey Vero cells after 72 hrs by sulforhodamine B assay
AID696200Inhibition of CDDP-induced FANCD2 monoubiquitination in human HeLa cells at 9 uM after 18 hrs by Western blot analysis2012Bioorganic & medicinal chemistry, Nov-01, Volume: 20, Issue:21
The antitumor agent doxorubicin binds to Fanconi anemia group F protein.
AID1546809Cytotoxicity against human HeLa cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID86074Cytotoxicity against HT-29 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID1421557Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID580234Cytotoxicity against human SW1116 cells assessed as cell proliferation inhibition rate at 10 ug/ml after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Mar-01, Volume: 21, Issue:5
Substrate-controlled chemoselective synthesis and potent cytotoxic activity of novel 5,6,7-triarylpyrido[2,3-d]pyrimidin-4-one derivatives.
AID462330Cytotoxicity against human K562 cells in presence of 10% fetal bovine serum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
AID1168508Cytotoxicity against human Bel7402 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1706711Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1481490Cytotoxicity against human K562/A02 cells overexpressing P-gp after 48 hrs by MTT assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
AID1637320Induction of apoptosis in human HeLa cells assessed as necrotic cells at 3 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometric analysis (Rvb = 21.45 +/- 0.78 %)2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID467996Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Oleanane-type triterpenoids from Aceriphyllum rossii and their cytotoxic activity.
AID1461762Cytotoxicity against human MCF7/ADR cells assessed as cell growth at 3 mM after 72 hrs relative to control2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1435296Dark toxicity in human M14 cells assessed as increase in LDH release at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1625738Resistance index, ratio of IC50 for vinblastine resistant/P-gp overexpressing human HCT8 cells to IC50 for human HCT8 cells2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID461389Antitumor activity against human COLO205 cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1355998Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID621708Binding affinity to human serum transferrin after 12 hrs at pH 7.4 by spectrofluorometer method2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID456253Cytotoxicity against human HCT15 cells after 4 days by ELISA reader assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
AID1398450Cytotoxicity against human PC3 cells after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.
AID1185515Cytotoxicity against human DU145 cells after 4 days by CCK-8 assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
AID333313Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1337471Inhibition of human DNA topoisomerase-2alpha at 100 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1352064Selectivity ratio of IC50 for human K562/A02 cells to IC50 for human K562 cells2018European journal of medicinal chemistry, Feb-10, Volume: 145Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
AID1318838Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
AID1441896Antiproliferative activity against human HCC1428 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
AID1776429Cytotoxicity against human PC-3 cells assessed as cell viability inhibition for 48 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Diverse Prenylated Bibenzyl Enantiomers from the Chinese Liverwort
AID484664Cytotoxicity against human COLO205 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1498577Growth inhibition of human MCF7/ADR cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID1168510Antitumor activity against mouse S180 cells allografted in mouse assessed as tumor growth inhibition at 1 umol/kg, ip for 7 consecutive days2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1546808Cytotoxicity against human SH-SY5Y cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID478272Induction of apoptosis in human HL60 cells assessed as increase of caspase 8 activity at 5 uM after 4 to 24 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1291709Antitumor activity against human HepG2 cells xenografted with nude mouse assessed as tumor weight at 5 mg/kg, iv administered every 2 days for 31 days2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
AID1227997Cytotoxic activity against human HCT116 cells by MTT method2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.
AID1337476Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1751130Cytotoxicity against human MCF7 cells assessed as reduction in cell viability by MTT assay
AID1327571Cytotoxicity against human A549 cells after 48 hrs by SRB assay2016Journal of natural products, 08-26, Volume: 79, Issue:8
Rhizovarins A-F, Indole-Diterpenes from the Mangrove-Derived Endophytic Fungus Mucor irregularis QEN-189.
AID1756027Cytotoxicity against human MV4-11 cells assessed as inhibition of cell growth measured after 72 hrs by Celltiter-Glo assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Discovery of Venturicidin Congeners and Identification of the Biosynthetic Gene Cluster from
AID460539Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
AID1166323Cytotoxicity against human PC3 cells after 48 hrs by SRB assay2014European journal of medicinal chemistry, Nov-24, Volume: 87β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents.
AID1815020Cytotoxicity against human PC-3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 08-27, Volume: 84, Issue:8
Cryptoyunnanones A-H, Complex Flavanones from
AID1577631Antiproliferative activity against human MDA-MB-436 cells measured after 72 hrs by Ez-cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID1785517Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay
AID376373Antitumor activity against mouse P388 cells1999Journal of natural products, Nov, Volume: 62, Issue:11
Synthesis of 11,12-epoxydrim-8,12-en-11-ol, 11,12-diacetoxydrimane, and warburganal from (-)-sclareol.
AID1168506Cytotoxicity against human K562 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID1637341Cytotoxicity against human MCF7 cells assessed as cell viability at 20 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1436224Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay2017European journal of medicinal chemistry, Jan-27, Volume: 126Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
AID1508156Cell cycle arrest in human MCF7 cells assessed as accumulation at S phase at 2 uM after 24 hrs by flow cytometric analysis (Rvb = 79.1%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1500601Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
AID1402294Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID1508159Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 2 uM after 48 hrs by flow cytometric analysis (Rvb = 8.1%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID459820Binding affinity to salmon sperm DNA assessed as melting temperature at 10 uM under low salt concentration by spectrophotometry2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.
AID735844Cytotoxicity against human K562 cells after 72 hrs by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Cytotoxic polyketide derivatives from the South China Sea sponge Plakortis simplex.
AID490203Cytotoxicity against human 786-0 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1288332Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
AID1754632Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1264613Cytotoxicity against human K562 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID1713810Cytotoxicity against human T47D cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
AID618834Cytotoxicity against human K562 cells after 2 days by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
AID478262Cytotoxicity against human vinblastine-resistant KBV1 cells after 72 hrs by MTT assay in presence of 24 mM ABC transporter inhibitor verapamil hydrochloride2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1546812Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1899070Resistant index, ratio IC50 for KB/VCR cells over IC50 for KB cells
AID1308431Cytotoxicity in rat H9c2 cells at 5 uM incubated for 24 hrs in presence of NAC by LDH release-based spectrofluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID462329Cytotoxicity against human HCT15 cells in presence of 10% fetal bovine serum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
AID1359650Antiproliferative activity against human MCF7 cells after 48 to 72 hrs by MTT assay2018European journal of medicinal chemistry, May-25, Volume: 152Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
AID1902208Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, Mar-15, Volume: 232Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
AID478261Cytotoxicity against human topotecan-resistant MCF7 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1404433Cytotoxicity against human HeLa cells assessed as decrease in cell viability by MTT assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Penicilindoles A-C, Cytotoxic Indole Diterpenes from the Mangrove-Derived Fungus Eupenicillium sp. HJ002.
AID480107Cytotoxicity against human MDA-MB-231 cells after 2 days by automatic ELISA reader system2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
AID1637350Cytotoxicity against human HeLa cells assessed as cell viability at 2 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID621711Binding affinity to human apo transferrin after 12 hrs at pH 4.8 by spectrofluorometer method2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID122106Antitumor activity against mice baering P388 leukemia (10e6 cells) implanted ip on day 0, after treatment with single ip dose 7.5 mg/kg on day 1.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID490206Cytotoxicity against human HT-29 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1202747Growth inhibition of human Saos2 cells by MTT method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
1,19-seco-Avermectin analogues from a ΔaveCDE mutant Streptomyces avermectinius strain.
AID1907346Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID549506Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.
AID1405494Cytotoxicity against human HPDE6c7 cells2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1867130Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
AID1851419Antiproliferative activity against human K562 cells assessed as inhibition of cell growth2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Synthesis and antitumor activity of a series of novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones derivatives.
AID467760Cytotoxicity against human DU145 cells by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
AID1401029Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
AID1435299Cytotoxicity against 7 mW/cm'2 irradiated rat H9c2 cells at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1358353Selectivity index, ratio of IC50 against human Aspc-1 cells under normoxic condition to IC50 for human Aspc-1 cells under hypoxic condition2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1895015Anticancer activity against human MCF7 cells assessed as inhibition of cell growth2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID1757275Antiproliferative activity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID1696721Cytotoxicity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by
AID1308433Induction of intracellular ROS accumulation in human U2OS cells at 5 uM incubated for 24 hrs by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1675631Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1387376Cytotoxicity against human A549 cells after 72 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Dinghupeptins A-D, Chymotrypsin Inhibitory Cyclodepsipeptides Produced by a Soil-Derived Streptomyces.
AID1817885Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by Ez-cytoX based microplate reader method2021European journal of medicinal chemistry, Dec-15, Volume: 226Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.
AID1625737Cytotoxicity against vinblastine resistant/P-gp overexpressing human HCT8 cells assessed as reduction in cell growth after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1435968Cytotoxicity against human A549 cells assessed as growth inhibition at 10 uM measured after 72 hrs by CCK-8 assay relative to control
AID1330743Cytotoxicity against human HeLa cells assessed as reduction in cell growth after 72 hrs by CCK8 assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
AID1441122Disruption of cancer stem cells spheroids derived from human BT474 cells at 20 uM after 3 days by microscopic analysis2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1583363Cytotoxicity against mouse 3T3 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID1308403Cytotoxicity in human U2OS/DX100 cells at 5 uM incubated for 24 hrs by LDH release-based spectrofluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1308424Cytotoxicity in rat H9c2 cells assessed as intracellular ROS accumulation at 5 uM incubated for 24 hrs by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID478104Cytotoxicity against human KB cells after 45 hrs by resazurin microplate assay2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Hopane-type triterpenes and binaphthopyrones from the scale insect pathogenic fungus Aschersonia paraphysata BCC 11964.
AID673202Antiproliferative activity against mouse BALB/3T3 cells after 72 hrs by SRB assay2012Bioorganic & medicinal chemistry, Aug-01, Volume: 20, Issue:15
Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
AID494521Inhibition of tubulin polymerization in human K562 cells2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by anthracenone-based oxime derivatives.
AID1508150Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1543250Cytotoxicity in human KB cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID1185752Cytotoxicity against human CCRF-CEM cells after 48 hrs by Alamar blue assay2014European journal of medicinal chemistry, 09-12, Volume: 84Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
AID478259Cytotoxicity against human topotecan-resistant MCF7 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1308416Drug uptake in human U2OS/DX100 cells at 5 uM incubated for 24 hrs by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1498374Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
AID1637407Resistance factor, ratio of IC50 for human K562/ADR cells to IC50 for human K562 cells2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
AID1671750Inhibition of TGF-beta1-induced cell migration in human SMMC-7721 cells at 0.5 uM incubated for 24 hrs by wound healing assay relative to control2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1355997Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID1543246Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID478252Cytotoxicity against human 518A2 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1436223Cytotoxicity against human HeLa cells assessed as cell growth at 10'-4 M after 48 hrs by SRB assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
AID494520Cell growth inhibition of human K562 cells after 48 hrs2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by anthracenone-based oxime derivatives.
AID1663789Anticancer activity against human Caco2 cells assessed as inhibition of cell proliferation2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Synthesis and evaluation of novel sulfonamide analogues of 6/7-aminoflavones as anticancer agents via topoisomerase II inhibition.
AID8824Cytotoxicity against A-498 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID1504775Cytotoxicity against human A549 cells by SRB assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Cephanolides A-J, Cephalotane-Type Diterpenoids from Cephalotaxus sinensis.
AID512239Anticancer activity against human A2780 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
AID1890787Cytotoxicity against human ACHN cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID1428410Cytotoxicity against multidrug resistant human MCF7 cells cultured in vinblastine free medium assessed as growth inhibition after 72 hrs by SRB assay
AID1402311Induction of DNA double stranded breaks in human SMMC7721 cells assessed as increase in H2AX phosphorylation at S139 at 0.8 uM after 72 hrs by Western blot analysis2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID490201Cytotoxicity against human KB cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID490200Cytotoxicity against human 769-P cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID718786Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Angucyclines from an insect-derived actinobacterium Amycolatopsis sp. HCa1 and their cytotoxic activity.
AID1762047Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
AID1428692Antiproliferative activity against human HCT15 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
AID1180307Cytotoxicity against human HeLa cells by SRB method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents.
AID599176Cytotoxicity against human HL60 cells after 2 days2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
AID1757274Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID689425Cytotoxicity against human KB cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
AID1869702Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay2022Journal of natural products, 07-22, Volume: 85, Issue:7
Suncheonosides E-M and Benzothioate Derivatives from the Marine-Derived
AID509770Reversal of P-gp-mediated multidrug-resistance in human KB/VCR cells assessed as increase in intracellular adriamycin accumulation at 4 uM after 1 hr by flow cytometry relative to control2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID1785519Resistance ratio of IC50 for human MCF-7 cells to IC50 for human MCF-7/ADR cells
AID1172773Anti-proliferative activity against human NCI-H23 cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1783256Cytotoxicity against human HCT116 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID636833Cytotoxicity against human MCF7 cells by resazurin microplate assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Lanostane and hopane triterpenes from the entomopathogenic fungus Hypocrella sp. BCC 14524.
AID509774Induction of adriamycin accumulation in human KB cells at 4 to 6 uM after 1 hr by flow cytometry2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID452684Cytotoxicity against human HeLa cells after 3 days2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID569515Cytotoxicity against human A2780 cells after 48 hrs by sulforhodamine B assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
AID459819Binding affinity to salmon sperm DNA assessed as change in melting temperature at 10 uM under low salt concentration by spectrophotometry2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.
AID1126866Cytotoxicity against mouse BALB/3T3 cells assessed as growth inhibition after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
AID1320983Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
AID1428415Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
AID1890791Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID633823Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1330744Cytotoxicity against human NCI-N87 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
AID1675630Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1401808Cytotoxicity against human MCF10A cells after 72 hrs by cell counting kit-8 analysis2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
AID1421548Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1421556Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1577580Antiproliferative activity against human DU145 cells measured after 72 hrs by EZ-Cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID357613Antiproliferative activity against mouse B16-BL6 cells assessed as cell viability after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
AID1320984Cytotoxicity against human K562 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
AID512162Cytotoxicity against human SiHa cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1638222Cytotoxicity against human Bel7042 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1421559Antiproliferative activity against human BxPC3 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1408890Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
AID1126870Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
AID599173Cytotoxicity against human HCT116 cells after 2 days2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
AID1617192Cytotoxicity against human NUGC3 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID736708Cytotoxicity against human A549 cells by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Steroids glycosylated with both D- and L-arabinoses from the South China Sea gorgonian Dichotella gemmacea.
AID1398448Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.
AID551372Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID1430413Cytotoxicity against human HeLa cells assessed as cell growth at 10'-5 M after 48 hrs by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
AID636832Cytotoxicity against human NCI-H187 cells by resazurin microplate assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Lanostane and hopane triterpenes from the entomopathogenic fungus Hypocrella sp. BCC 14524.
AID460542Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
AID1625415Cytotoxicity against human Caco2 cells assessed as reduction in cell viability by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.
AID1132906Binding affinity to calf thymus DNA assessed as change in melting temperature at 5 uM by spectrophotometer analysis1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID566854Cytotoxicity against human HL60 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1318839Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
AID1363195Antiproliferative activity against human HeLa cells after 72 hrs by EZ-CYTOX reagent based assay2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.
AID619816Cytotoxicity against human 769-P cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID460538Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
AID1401809Cytotoxicity against human T47D cells after 72 hrs by cell counting kit-8 analysis2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
AID303685Inhibition of porcine brain tubulin polymerization2007Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
AID1706708Antiproliferative activity against human A549 cells assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1523994Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
AID478276Induction of apoptosis in human 518A2 cells assessed as increase of caspase 3 activity at 5 uM measured up to 12 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1543244Cytotoxicity in human NCI-H1299 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID1625850Toxicity in mouse xenografted with P-gp overexpressing human MCF7/ADR cells assessed as body weight loss at 4 mg/kg, iv qd administered every 2 days measured during compound dosing2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1168527Toxicity in mouse S180 cells allografted mouse assessed as spleen index at 1 umol/kg, ip for 7 consecutive days measured 24 hrs after last dose (Rvb = 7.25 +/- 1.60 No_unit)2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID484657Cytotoxicity against human ZR-75-1 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1391798Cytotoxicity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
AID1657550Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
AID1637352Cytotoxicity against human HeLa cells assessed as cell viability at 0.5 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1264612Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID1423927Cytotoxicity against human HCT116 cells assessed as inhibition of growth incubated for 72 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
AID1675628Cytotoxicity against human ASPC1 cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1355291Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID1236895Cytotoxicity against human T47D cells incubated from day 2 to day 4 by CCK8 assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
AID1833615Cytotoxicity against human A549 cells assessed as cell growth inhibition by SRB assay2021Journal of natural products, 11-26, Volume: 84, Issue:11
Sublyratins A-O, Labdane-Type Diterpenoids from
AID249855Percent control of human mammary adenocarcinoma MCF-7 cell line proliferation at 3 ng/mL2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
AID718784Cytotoxicity against human KB cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Angucyclines from an insect-derived actinobacterium Amycolatopsis sp. HCa1 and their cytotoxic activity.
AID1638227Cytotoxicity against human A549/TAX cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID461181Antitumor activity against human HL60 cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1410126Growth inhibition of human HL60 cells measured after 3 days by trypan blue assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Bioassay- and Chemistry-Guided Isolation of Scalemic Caged Prenylxanthones from the Leaves of Garcinia bracteata.
AID1437482Cytotoxicity against human HL60 cells assessed as reduction in cell viability by MTT assay2017Journal of natural products, 01-27, Volume: 80, Issue:1
Penicisulfuranols A-F, Alkaloids from the Mangrove Endophytic Fungus Penicillium janthinellum HDN13-309.
AID1638230Selectivity ratio of IC50 for human A549 cells to IC50 for human A549/TAX cells2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1751133Cytotoxicity against human L02 cells assessed as reduction in cell viability by MTT assay
AID1486952Inhibition of ABCB1 in human K562/A02 cells assessed as potentiation of adriamycin-induced cytotoxicity by measuring reduction in ADR IC50 at 5 uM measured after 48 hrs by MTT assay relative to ADR alone2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
AID1706707Antiproliferative activity against human K562 cells assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1887100Cytotoxicity against human K562 cells assessed as reduction in cell viability by MTT assay
AID1441109Cytotoxicity against human DU145 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID478275Induction of apoptosis in human 518A2 cells assessed as increase of caspase 8 activity at 5 uM measured up to 12 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1278416Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1504837Cytotoxicity against human PC3 cells assessed as reduction in cell viability by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Bibenzyl-Based Meroterpenoid Enantiomers from the Chinese Liverwort Radula sumatrana.
AID1490963Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID592934Cytotoxicity against human COLO205 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID452682Cytotoxicity against human HCT116 cells after 3 days2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
AID1594688Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID334279Antiproliferative activity against mouse 26-L5 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID478257Cytotoxicity against human vinblastine-resistant KBV1 cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1163658Toxicity in human HepG2 cells xenografted Balb/C mouse assessed as body weight changes at 5 mg/kg, iv dosed every 2 days for 11 days2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
AID55161Inhibition of [3H]thymidine incorporation into proliferating L1210 cells.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID650183Cytotoxicity against human K562 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID460541Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
AID1546810Cytotoxicity against human U87 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1577632Antiproliferative activity against human HCC70 cells measured after 72 hrs by Ez-cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID1671739Antiproliferative activity against human SMMC-7721 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID551373Cytotoxicity against human COLO205 assessed as inhibition of cell growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID718783Cytotoxicity against human GHOST-R5X4 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Angucyclines from an insect-derived actinobacterium Amycolatopsis sp. HCa1 and their cytotoxic activity.
AID1663787Anticancer activity against human HepG2 cells assessed as inhibition of cell proliferation2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Synthesis and evaluation of novel sulfonamide analogues of 6/7-aminoflavones as anticancer agents via topoisomerase II inhibition.
AID1851422Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Synthesis and antitumor activity of a series of novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones derivatives.
AID334278Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID1905036Antiproliferative activity against human HCT-8 cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID633820Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1435969Cytotoxicity against human K562 cells assessed as growth inhibition at 10 uM measured after 72 hrs by CCK-8 assay relative to control
AID592932Cytotoxicity against human Gurav cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1894515Antitumor activity against mouse CCRF S-180 cells allografted in ICR mouse assessed as tumor growth inhibition at 0.1 micromol/kg, iv administered for 7 days relative to control2021European journal of medicinal chemistry, Apr-15, Volume: 216β-Carbolines as potential anticancer agents.
AID1637328Induction of apoptosis in human HeLa cells assessed as viable cells at 3 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometric analysis (Rvb = 46.00 +/- 0.56 %)2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1164703Cytotoxicity against human A549 cells after 24 hrs by MTT assay2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Notolutesins A-J, dolabrane-type diterpenoids from the Chinese liverwort Notoscyphus lutescens.
AID1370453Drug localization in human HepG2 cell nucleus assessed as doxorubicin conjugates accumulation at 10 uM after 24 hrs by DAPI staining-based fluorescence microscopic analysis2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
AID1668784Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cytotoxic Heptaketides from the Endolichenic Fungus
AID1505071Cytotoxicity against human G3K cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID1386174Cytotoxicity against human A549 cells after 48 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Cytotoxic p-Terphenyls from the Endolichenic Fungus Floricola striata.
AID1421553Antiproliferative activity against human HL60 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1815018Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 08-27, Volume: 84, Issue:8
Cryptoyunnanones A-H, Complex Flavanones from
AID1370450Drug uptake in human HepG2 cells assessed as doxorubicin conjugates accumulation at 10 uM after 6 hrs by fluorescence assay2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
AID138194Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 8 mg/kg1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID154432Cytotoxicity against PACA-2 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID734494Growth inhibition against human HT-29 cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID1405496Therapeutic index, ratio of IC50 for human FHC cells to IC50 for human HCT116 cells2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1821806Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1185778Growth inhibition of human PC3 cells at 10 uM after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1381568Cytotoxicity against human HepG2 cells by SRB assay
AID1751127Cytotoxicity against human A-427 cells assessed as reduction in cell viability by MTT assay
AID1505076Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID599174Cytotoxicity against human DU145 cells after 2 days2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
AID1783257Cytotoxicity against human HepG2 cells assessed as inhibition rate at 2.5 uM incubated for 72 hrs by MTT assay relative to control
AID1895012Anticancer activity against human HCT-116 cells assessed as inhibition of cell growth by MTT assay2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID122234Antitumor activity against mice bearing P388 leukemia implanted ip on day 0, after treatment with single iv dose 10 mg/kg on day 1.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1236897Cytotoxicity against human HeLa cells incubated from day 2 to day 4 by CCK8 assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
AID1428694Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
AID1671755Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as increase in TGF-beta1 reduced E-cadherin expression at 0.5 uM incubated for 48 hrs by Western blot analysis2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1543242Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1326554Antiproliferative activity against human ER-triple negative MDA-MB-468 cells measured after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Discovery and development of natural product oridonin-inspired anticancer agents.
AID736707Cytotoxicity against human MG63 cells by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Steroids glycosylated with both D- and L-arabinoses from the South China Sea gorgonian Dichotella gemmacea.
AID357612Antiproliferative activity against human HT1080 cells assessed as cell viability after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
AID1441108Cytotoxicity against human MIAPaCa2 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1672168Cytotoxicity against human HEK293 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia.
AID1888034Antiproliferative activity against human HeLa cells after 72 hrs by EZ-Cytox colorimetric assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.
AID1272408Antiproliferative activity against human MCF7 cells after 96 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells.
AID1776431Cytotoxicity against human MCF-7 cells assessed as cell viability inhibition for 48 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Diverse Prenylated Bibenzyl Enantiomers from the Chinese Liverwort
AID1330741Cytotoxicity against human HCT15 cells assessed as reduction in cell growth after 72 hrs by CCK8 assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
AID1180308Cytotoxicity against human MCF7 cells by SRB method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents.
AID1887101Cytotoxicity against human L02 cells assessed as reduction in cell viability by SRB assay
AID1185755Cytotoxicity against normal human PBMC assessed as reduction in cell viability at 10 times anti-leukemic IC50 after 48 hrs by Alamar blue assay2014European journal of medicinal chemistry, 09-12, Volume: 84Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
AID510627Cytotoxicity against human DU145 cells after 4 days by MTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
AID595894Cytotoxicity against human NCI-H187 cells after 45 hrs by resazurin microplate assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive compounds from the scale insect pathogenic fungus Conoideocrella tenuis BCC 18627.
AID1278450Selectivity index, ratio IC50 for human HL60 cells to IC50 for human HL60/ADR cells2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID478305Cytotoxicity against human 518A2 cells assessed as increase in ROS production at 5 uM after 24 hrs by NBT reduction assay relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1126889Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
AID1508157Cell cycle arrest in human MCF7 cells assessed as accumulation at G0/G1 phase at 2 uM after 48 hrs by flow cytometric analysis (Rvb = 34.2%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1435967Cytotoxicity against human Jurkat cells assessed as growth inhibition at 10 uM measured after 72 hrs by CCK-8 assay relative to control
AID1543247Cytotoxicity in human U251 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID673201Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay2012Bioorganic & medicinal chemistry, Aug-01, Volume: 20, Issue:15
Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
AID1132910Partition coefficient, log P of the compound1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1882811Antitumor activity against mouse Sarcoma-180 cells xenografted in ip dosed ICR mouse assessed as tumor growth inhibition rate administered daily for 5 days relative to control2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1126867Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
AID23283Partition coefficient (log P) was the log of ratio of concentration in octanol / water partitioned concentration in phosphate buffer at pH 7.4.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID378843Cytotoxicity against human Hep G2 cells2006Journal of natural products, Oct, Volume: 69, Issue:10
Bioactive guaianolides from siyekucai (Ixeris chinensis).
AID1439746Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID1706710Antiproliferative activity against human HCC1428 cells assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1308425Cytotoxicity in rat H9c2 cells assessed as intracellular ROS accumulation at 5 uM incubated for 24 hrs in presence of hydroxocobalamin by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1524534Resistance index, ratio of IC50 for human MCF7/ADR cells to IC50 for human MCF7 cells
AID1410127Growth inhibition of human K562 cells measured after 3 days by trypan blue assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Bioassay- and Chemistry-Guided Isolation of Scalemic Caged Prenylxanthones from the Leaves of Garcinia bracteata.
AID467759Cytotoxicity against human HT-29 cells by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
AID221147Thermal denaturation for stabilization of helical DNA by the compound1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1188100Cytotoxicity against human COLO205 cells assessed as growth inhibition at 1 uM after 48 hrs by sulforhodamine B assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies.
AID1757280Antiproliferative activity against ADR-resistant human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID1490965Cytotoxicity against human K562 cells after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1871293Cytotoxicity against human A549 cells assessed as cell growth inhibition2021European journal of medicinal chemistry, Jan-15, Volume: 210Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
AID1583357Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
AID1612613Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID566858Cytotoxicity against human MCF7 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID467758Cytotoxicity against human HeLa cells by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
AID1638225Cytotoxicity against human MCF7/ADR cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1751126Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
AID490205Cytotoxicity against human A375 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID619898Cytotoxicity against human 22Rv1 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1546804Cytotoxicity against human MGC803 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1486761Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.
AID1890790Cytotoxicity against human NUGC-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID1762254Cytotoxicity against human HT-1080 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
AID1277893Cytotoxicity against human HCT116 cells assessed as cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives.
AID1352063Cytotoxicity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTS assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
AID376374Antitumor activity against human A549 cells1999Journal of natural products, Nov, Volume: 62, Issue:11
Synthesis of 11,12-epoxydrim-8,12-en-11-ol, 11,12-diacetoxydrimane, and warburganal from (-)-sclareol.
AID1426669Antitumor activity against P-gp overexpressing/drug resistant human K562/A02 cells xenografted in BALB/c nude mouse assessed as reduction in tumor weight at 4 mg/kg, iv administered every other day for 21 days measured post last dose2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1637344Cytotoxicity against human MCF7 cells assessed as cell viability at 0.5 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1355286Cytotoxicity against human ACHN cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID1504776Cytotoxicity against human KB cells by SRB assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Cephanolides A-J, Cephalotane-Type Diterpenoids from Cephalotaxus sinensis.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID478006Antiproliferative activity against human MCF7 cells after 72 hrs by sulforhodamine B assay2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
AID1132909Inhibition of RNA synthesis in mouse L1210 cells1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1355996Cytotoxicity against human K562 cells after 72 hrs by MTT assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA.
AID1318829Cytotoxicity against human QG56 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
AID1337589Antiproliferative activity against human MCF7 cells measured after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
AID1696719Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by
AID650181Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID1851421Antiproliferative activity against human A549 cells assessed as inhibition of cell growth2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Synthesis and antitumor activity of a series of novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones derivatives.
AID1163665Toxicity in human HepG2 cells xenografted Balb/C mouse assessed as mortality level at 5 mg/kg, iv dosed every 2 days for 11 days2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
AID461388Antitumor activity against human Hs 578T cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID592935Cytotoxicity against human DWD cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1126869Cytotoxicity against human LoVo cells assessed as growth inhibition after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
AID1426668Antitumor activity against P-gp overexpressing/drug resistant human K562/A02 cells xenografted in BALB/c nude mouse assessed as reduction in tumor size at 4 mg/kg, iv administered every other day for 21 days measured post last dose2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1821805Resistance index, ratio of IC50 for antiproliferative activity against human MCF7/ADR cells to IC50 for antiproliferative activity against human MCF7 cells2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1421560Antiproliferative activity against human PANC1 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1546811Cytotoxicity against human K562 cells after 72 hrs by MTT assay2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1517674Antiproliferative activity against human Bel7402/5-FU incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-01, Volume: 183Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
AID699782Growth inhibition of human HT-29 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Synthesis and antimitotic and tubulin interaction profiles of novel pinacol derivatives of podophyllotoxins.
AID1431558Cytotoxicity against human KG1a cells assessed as decrease in cell proliferation after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
AID1378627Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID718785Cytotoxicity against human A375 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Angucyclines from an insect-derived actinobacterium Amycolatopsis sp. HCa1 and their cytotoxic activity.
AID1754633Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID599175Cytotoxicity against human MDA-MB-231 cells after 2 days2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
AID1441898Antiproliferative activity against paclitaxel-resistant human PC3 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
AID490209Cytotoxicity against human MCF7 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1489128Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID333315Cytotoxicity against human doxorubicin-resistant LoVo cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1428414Cytotoxicity against human HCT15 cells assessed as growth inhibition after 72 hrs by SRB assay
AID1426655Anti-proliferative activity against P-gp overexpressing/drug resistant human K562/A02 cells measured after 72 hrs by MTS assay2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1163672Antitumor activity against human HepG2 cells xenografted in Balb/C mouse assessed as tumor mass changes at 5 mg/kg, iv dosed every 2 days for 11 days2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
AID478016Antiproliferative activity against human KB cells after 72 hrs by sulforhodamine B assay2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
AID1421558Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID467761Cytotoxicity against human MDA-MB-231 cells by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
AID484655Cytotoxicity against human A549 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID509771Reversal of P-gp-mediated multidrug-resistance in human KB/VCR cells assessed as increase in intracellular adriamycin accumulation at 8 uM after 1 hr by flow cytometry relative to control2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID1236894Cytotoxicity against human HCT15 cells incubated from day 2 to day 4 by CCK8 assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
AID1524005Cytotoxicity against mouse 3T3 cells measured after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
AID1057308Growth inhibition of human MCF10A cells after 72 hrs by CellTiter-Blue assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
AID1132908Inhibition of DNA synthesis in mouse L1210 cells1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1768122Cytotoxicity against human HeLa cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 07-23, Volume: 84, Issue:7
Iridoid Constituents of
AID1525108Cytotoxicity against human LO2 cells assessed as reduction in cell viability by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Strepantibins A-C: Hexokinase II Inhibitors from a Mud Dauber Wasp Associated Streptomyces sp.
AID1508158Cell cycle arrest in human MCF7 cells assessed as accumulation at S phase at 2 uM after 48 hrs by flow cytometric analysis (Rvb = 57.7%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1899068Antiproliferative activity against human KB cells measured after 72 hrs by SRB assay
AID1637351Cytotoxicity against human HeLa cells assessed as cell viability at 1 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1697199Cytotoxicity against human NCI-H23 cells by colorimetric method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
AID480108Cytotoxicity against human HeLa cells after 2 days by automatic ELISA reader system2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
AID1308411Cytotoxicity in rat H9c2 cells at 5 uM incubated for 24 hrs by LDH release-based spectrofluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1423926Cytotoxicity against human NCI-H460 cells assessed as inhibition of growth incubated for 72 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
AID1821804Antiproliferative activity against human MCF7/ADR cells assessed as reduction in cell viability after 48 hrs by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
AID1625723Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1489126Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID1875130Growth inhibition of human NUGC-3 cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID1132916In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 1 mg/kg, ip administered on days 1 to 9 relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1288091Cytotoxicity against human DU145 cells after 48 hrs by CCK8 assay2016European journal of medicinal chemistry, May-04, Volume: 113A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.
AID478270Induction of apoptosis in human HL60 cells assessed as increase of caspase 3 activity at 5 uM after 4 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1879218Antiproliferative activity against human T47D cells assessed as inhibition of cell proliferation2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships.
AID1278451Selectivity index, ratio IC50 for human KG1a cells to IC50 for human HL60 cells2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1423928Cytotoxicity against human HeLa cells assessed as inhibition of growth incubated for 72 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
AID699781Growth inhibition of human A549 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Synthesis and antimitotic and tubulin interaction profiles of novel pinacol derivatives of podophyllotoxins.
AID1430411Cytotoxicity against human HeLa cells assessed as cell growth at 10'-7 M after 48 hrs by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
AID1404432Cytotoxicity against human A549 cells assessed as decrease in cell viability by MTT assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Penicilindoles A-C, Cytotoxic Indole Diterpenes from the Mangrove-Derived Fungus Eupenicillium sp. HJ002.
AID592926Cytotoxicity against human ZR-75-1 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1359659Resistance index, ratio of IC50 for human MCF7/ADR cells to IC50 for human MCF7 cells2018European journal of medicinal chemistry, May-25, Volume: 152Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
AID1132921Cardiotoxicity in rat EEG model relative to adriamycin1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID1638229Selectivity ratio of IC50 for human MCF7 cells to IC50 for human MCF7/ADR cells2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID569499Cytotoxicity against human OVCAR8 cells after 48 hrs by sulforhodamine B assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
AID478306Cytotoxicity against human 518A2 cells assessed as increase in ROS production at 5 uM after 72 hrs by NBT reduction assay relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID733309Growth inhibition of human MCF7 cells at 2 uM after 48 hrs by MTT assay2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, structure activity relationship and mode of action of 3-substitutedphenyl-1-(2,2,8,8-tetramethyl-3,4,9,10-tetrahydro-2H,8H-pyrano[2,3-f]chromen-6-yl)-propenones as novel anticancer agents in human leukaemia HL-60 cells.
AID1265154Growth inhibition of human HeLa cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Isolation and Structure of Kurahyne B and Total Synthesis of the Kurahynes.
AID1902211Cytotoxicity against human Eca-109 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, Mar-15, Volume: 232Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
AID566779Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1486982Cytotoxicity against human K562/A02 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
AID484661Cytotoxicity against human Gurav cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1754634Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1408894Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability at 100 uM after 48 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
AID1281567Potency index, ratio of DHEA IC50 to compound IC50 for antiproliferative activity against human T47D cells after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
AID1577581Antiproliferative activity against human HeLa cells measured after 72 hrs by EZ-Cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID1594848Cytotoxicity in human A549 cells assessed as inhibition of cell viability incubated for 72 hrs by CCK-8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
17- nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei.
AID1546806Cytotoxicity against human Bel7402 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1751132Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
AID1287951Cytotoxicity against human HCT15 cells after 3 days by CCK8 assay2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.
AID1637348Cytotoxicity against human HeLa cells assessed as cell viability at 10 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1165134Induction of DNA intercalation in Escherichia coli pBR322 DNA at 100 uM by DNA gel electrophoresis2014European journal of medicinal chemistry, Oct-30, Volume: 86Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomeraseIIα and antitumor agents.
AID1675629Cytotoxicity against human U87 cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1776432Cytotoxicity against human NCI-H12199 cells assessed as cell viability inhibition for 48 hrs by MTT assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Diverse Prenylated Bibenzyl Enantiomers from the Chinese Liverwort
AID249858Percent control of human mammary adenocarcinoma MCF-7 cell line proliferation at 300 ng/mL2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
AID1172772Anti-proliferative activity against human MDA-MB-231 cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1906033Antiproliferative activity against human MCF7/ADR cells after 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
AID1612626Antiproliferative activity against human ADR-resistant Bel7402/ADR cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1671757Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as decrease in TGF-beta1-induced MMP9 expression at 0.5 uM incubated for 48 hrs by Western blot analysis2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID633822Cytotoxicity against human HBL100 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1867129Cytotoxicity against human ASPC1 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay2022Journal of natural products, 04-22, Volume: 85, Issue:4
Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
AID1075860Cytotoxicity against human MCF7 cells assessed as growth inhibition by SRB assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and IIα by its cytotoxic β-carboline alkaloids.
AID490202Cytotoxicity against human BCG823 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1895013Anticancer activity against human HepG2 cells assessed as inhibition of cell growth by MTT assay2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID1426445Antiproliferative activity against human K562 cells after 48 hrs by Alamar blue dye based neubauer hemocytometer method2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization.
AID1337475Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1408893Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
AID1168526Toxicity in mouse S180 cells allografted mouse assessed as kidney weight at 1 umol/kg, ip for 7 consecutive days measured 24 hrs after last dose (Rvb = 0.16 +/- 0.04 g)2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID619822Cytotoxicity against human HT-29 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1358350Selectivity index, ratio of IC50 against human PANC1 cells under normoxic condition to IC50 for human PANC1 cells under hypoxic condition2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID566857Cytotoxicity against human MCF7 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1524522Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
AID592695Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B based ELISA2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
AID1594690Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID1288094Cytotoxicity against human HeLa cells after 48 hrs by CCK8 assay2016European journal of medicinal chemistry, May-04, Volume: 113A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.
AID484660Cytotoxicity against human KB cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1441128Cytotoxicity against human JIMT1 cells assessed as decrease in cell viability up to 8 uM after 48 hrs in presence of pan-caspase inhibitor QVD-OPh by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1308436Induction of intracellular ROS accumulation in human U2OS/DX580 cells at 5 uM incubated for 24 hrs by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1504778Cytotoxicity against human HL60 cells by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Cephanolides A-J, Cephalotane-Type Diterpenoids from Cephalotaxus sinensis.
AID452683Cytotoxicity against human MDA-MB-231 cells after 3 days2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
AID484658Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID461180Antitumor activity against human CCRF-CEM cells2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents.
AID1637332Induction of apoptosis in human HeLa cells assessed as early apoptotic cells at 3 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometric analysis (Rvb = 0.05 +/- 0.07 %)2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1637338Induction of apoptosis in human HeLa cells assessed as caspase 3 activation at 0.75 to 3 uM after 24 hrs by colorimetric analysis2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1355288Cytotoxicity against human MDA-MB-231 cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID156025Cytotoxicity against PC-3 cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID1185777Growth inhibition of human Bcap37 cells at 10 uM after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1193350Growth inhibition of human PC3 cells by colorimetric MTT assay2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Nine new diterpenes from the leaves of plantation-grown Cunninghamia lanceolata.
AID1612619Antiproliferative activity against human taxol-resistant HCT8/T cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID382550Cytotoxicity against human KB cells by MTT assay2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Anti-tumor 12-deoxyphorbol esters from Euphorbia cornigera.
AID1899074Antiproliferative activity against human K562/Adr cells measured after 72 hrs by SRB assay
AID1671756Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as decrease in TGF-beta1-induced vimentin expression at 0.5 uM incubated for 48 hrs by Western blot analysis2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1905033Antiproliferative activity against human A549 cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1615740Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 24 hrs by SRB assay2019Journal of natural products, 09-27, Volume: 82, Issue:9
Pyrimidine Nucleosides from
AID1402304Induction of apoptosis in human SMMC7721 cells assessed as apoptotic cells at 3.2 uM after 72 hrs by FITC-Annexin-V/7AAD/propidium iodide staining based flow cytometry relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID1075859Cytotoxicity against human UACC62 cells assessed as growth inhibition by SRB assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and IIα by its cytotoxic β-carboline alkaloids.
AID1637406Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
AID1671764Inhibition of epithelial-mesenchymal transition in human SMMC-7721 cells assessed as decrease in TGF-beta1-induced MMP9 expression at 0.5 uM incubated for 48 hrs by immunofluorescence staining based laser-scanning confocal microscope2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID335971Cytotoxicity against human HCT8 cells
AID1370456Cytotoxicity against human HepG2 cells assessed as cell viability up to 70 uM after 2 hrs by MTS assay2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
AID1423925Cytotoxicity against human BGC823 cells assessed as inhibition of growth incubated for 72 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
AID478304Induction of apoptosis in human HL60 cells assessed as appearance of intact mitochondria in cytosol at 5 uM after 18 hrs using JC1 dye relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1126887Cytotoxicity against human MV4-11 cells assessed as cell viability after 72 hrs by MTT assay2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
AID478299Induction of apoptosis in human 518A2 cells assessed as increase of Bcl-2 mRNA expression at 5 uM up to 24 hrs by Western blot analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1768120Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 07-23, Volume: 84, Issue:7
Iridoid Constituents of
AID1543249Cytotoxicity in human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID1320985Cytotoxicity against human HCC1428 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
AID1358351Cytotoxicity against human Aspc-1 cells after 72 hrs under normoxic condition by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1163589Resistance index, ratio of IC50 for adriamycin resistant human MCF7 cells to IC50 for parental human MCF7 cells2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
AID1907345Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID1637349Cytotoxicity against human HeLa cells assessed as cell viability at 5 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1882810Anticancer activity against human SNU1 cells assessed as reduction in cell viability for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1421550Antiproliferative activity against human HCT116 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID689428Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
AID467997Cytotoxicity activity against mouse LLC cells after 48 hrs by MTT assay2009Journal of natural products, Aug, Volume: 72, Issue:8
Oleanane-type triterpenoids from Aceriphyllum rossii and their cytotoxic activity.
AID1264618Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID1907350Selectivity index, ratio of IC50 for Cytotoxic activity against human MCF-10A cells to IC50 for antiproliferative activity against human NCI-ADR-RES cells2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID1508155Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 2 uM after 24 hrs by flow cytometric analysis (Rvb = 2.35%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
AID1308415Drug uptake in human U2OS/DX30 cells at 5 uM incubated for 24 hrs by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1321046Cytotoxicity against human HT1080 cells assessed as reduction cell viability after 72 hrs by WST8-based colorimetric analysis2016Journal of natural products, 07-22, Volume: 79, Issue:7
Isolation and Structure Elucidation of Cytotoxic Saccharothriolides D to F from a Rare Actinomycete Saccharothrix sp. and Their Structure-Activity Relationship.
AID1436221Cytotoxicity against human HeLa cells assessed as cell growth at 10'-6 M after 48 hrs by SRB assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
AID592927Cytotoxicity against human A549 cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID334275Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay2002Journal of natural products, May, Volume: 65, Issue:5
Constituents of Chinese propolis and their antiproliferative activities.
AID619899Cytotoxicity against human MCF7 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1288620Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
AID621712Antiproliferative activity against human A549 cells by MTT assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
AID1633071Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.
AID592422Cytotoxicity against human HL60 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Trigonosins A-F, daphnane diterpenoids from Trigonostemon thyrsoideum.
AID1462339Cytotoxicity against African green monkey Vero cells assessed as total inhibition of cell growth after 72 hrs by sulforhodamine B assay
AID1594721Cytotoxicity against human HL60 cells measured after 72 hrs by CCK8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Cytotoxic Tigliane Diterpenoids from Croton damayeshu.
AID734087Growth inhibition against human IGROV-ET cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID1308410Drug uptake in rat H9c2 cells at 5 uM incubated for 24 hrs by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID509753Cytotoxicity against human KB/VCR cells expressing Pgp after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID592696Cytotoxicity against human KB cells after 48 hrs by sulforhodamine B based ELISA2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
AID1132917In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.5 mg/kg, ip administered on days 1 to 9 relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
AID509772Reversal of P-gp-mediated multidrug-resistance in human KB/VCR cells assessed as increase in intracellular adriamycin accumulation at 16 uM after 1 hr by flow cytometry relative to control2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID1426673Antitumor activity against P-gp overexpressing/drug resistant human K562/A02 cells xenografted in BALB/c nude mouse assessed as tumor growth inhibition at 4 mg/kg, iv administered every other day for 21 days measured post last dose relative to control2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID303684Antiproliferative activity against human K562 cells after 48 hrs2007Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
AID484663Cytotoxicity against human A2780 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1185776Growth inhibition of human MGC803 cells at 10 uM after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1500606Antiproliferative activity against human MCF7/ADR cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
AID1675633Cytotoxicity against human HL-60 cells assessed as reduction in cell viability by MTT assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID103239Cytotoxicity against MCF-7ADR cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID1637405Antiproliferative activity against human K562/ADR cells after 72 hrs by CCK8 assay2016Bioorganic & medicinal chemistry letters, 09-15, Volume: 26, Issue:18
Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
AID452929Cytotoxicity against human HL60 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Two novel neo-clerodane diterpenoids from Scutellaria barbata.
AID1815019Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 08-27, Volume: 84, Issue:8
Cryptoyunnanones A-H, Complex Flavanones from
AID1185516Cytotoxicity against human HCT15 cells after 4 days by CCK-8 assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
AID490286Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID1751128Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by MTT assay
AID1498581Resistance factor, ratio of IC50 for human MDA-MB-231/ADR cells to IC50 for human MDA-MB-231 cells2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID1500610Resistance index, ratio of IC50 for human MCF7/ADR cells to IC50 for human MCF7 cells2017European journal of medicinal chemistry, Sep-29, Volume: 138Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
AID1541626Cytotoxicity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Glucoconjugated Monoterpene Indole Alkaloids from
AID1400965Antiproliferative activity in human K562 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Aug-18, Volume: 136Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome.
AID1277892Cytotoxicity against human HepG2 cells assessed as cell viability after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives.
AID1075861Cytotoxicity against human 786-0 cells assessed as growth inhibition by SRB assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and IIα by its cytotoxic β-carboline alkaloids.
AID1421554Antiproliferative activity against human K562 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID357611Antiproliferative activity against mouse Colon 26-L5 cells assessed as cell viability after 72 hrs by MTT assay2001Journal of natural products, Sep, Volume: 64, Issue:9
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
AID1882747Anticancer activity against human SMMC-7721 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1754635Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1355290Cytotoxicity against human NUGC3 cells assessed as inhibition of cell proliferation measured after 72 hrs by sulforhodamine B assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae.
AID1401810Cytotoxicity against human DU145 cells after 72 hrs by cell counting kit-8 analysis2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
AID512159Cytotoxicity against human ZR-75-1 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID478302Induction of apoptosis in human 518A2 cells assessed as appearance of intact mitochondria in cytosol at 5 uM after 18 hrs using JC1 dye relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID566853Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1185754Cytotoxicity against human K562 cells after 48 hrs by Alamar blue assay2014European journal of medicinal chemistry, 09-12, Volume: 84Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
AID566859Cytotoxicity against human MCF7 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1751131Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay
AID512241Anticancer activity against human SiHa cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
AID618835Cytotoxicity against human K562/A02 cells after 2 days by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
AID1785518Antiproliferative activity against human MCF-7/ADR cells incubated for 72 hrs by MTT assay
AID512163Cytotoxicity against human GURAV cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID478301Induction of apoptosis in human 518A2 cells assessed as appearance of intact mitochondria in cytosol at 5 uM after 6 hrs using JC1 dye relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1871299Cytotoxicity against human HL-60 cells assessed as cell growth inhibition2021European journal of medicinal chemistry, Jan-15, Volume: 210Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
AID1684109Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTT assay
AID1278417Cytotoxicity against human HL60/ADR cells after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
AID1428693Antiproliferative activity against human T47D cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
AID1594849Cytotoxicity in human HL60 cells assessed as inhibition of cell viability incubated for 72 hrs by CCK-8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
17- nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei.
AID478274Induction of apoptosis in human HL60 cells assessed as increase of caspase 9 activity at 5 uM after 12 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1902209Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, Mar-15, Volume: 232Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
AID333314Cytotoxicity against human LoVo cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1617195Cytotoxicity against human PC3 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID1168523Toxicity in mouse S180 cells allografted mouse assessed as brain weight at 1 umol/kg, ip for 7 consecutive days measured 24 hrs after last dose (Rvb = 0.30 +/- 0.02 g)2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID398902Cytotoxicity against human HCT8 cells1997Journal of natural products, Jun, Volume: 60, Issue:6
Cytotoxic and antiplatelet aggregation principles from Aglaia elliptifolia.
AID1126890Cytotoxicity against human HCT116 cells assessed as cell viability after 72 hrs by SRB assay2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
AID1901896Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability at 10 uM after 72 hrs by CCK-8 assay relative to control2022Bioorganic & medicinal chemistry, 03-01, Volume: 57Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
AID551370Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID1882746Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID378841Cytotoxicity against human WI38 cells2006Journal of natural products, Oct, Volume: 69, Issue:10
Bioactive guaianolides from siyekucai (Ixeris chinensis).
AID1906054Reversal index, ratio of IC50 for antiproliferative activity against MCF7 cells over IC50 for MCF7/ADR cells2022European journal of medicinal chemistry, May-05, Volume: 235Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
AID460540Cytotoxicity against human DU145 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
AID650184Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID1408892Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
AID1887102Cytotoxicity against human H69AR cells assessed as reduction in cell viability by SRB assay
AID1405495Cytotoxicity against mouse 3T3 cells2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID404064Cytotoxicity against mouse 26-L5 cells after 24 hrs by MTT assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Chemical constituents of Brazilian propolis and their cytotoxic activities.
AID735846Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Cytotoxic polyketide derivatives from the South China Sea sponge Plakortis simplex.
AID1391799Cytotoxicity against human K562/A02 cells overexpressing P-gp assessed as reduction in cell viability after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
AID1637339Cytotoxicity against human MCF7 cells assessed as cell viability at 2 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1696722Cytotoxicity against human HL-60 cells assessed as reduction in cell viability after 48 hrs by MTT assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by
AID1264617Cytotoxicity against human HO8910 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID452680Cytotoxicity against human DU145 cells after 3 days2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
AID1402295Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
AID1905028Resistance index, ratio of IC50 for antiproliferative activity against human vincristine-resistant HCT-8/VCR cells to IC50 for antiproliferative activity against HCT-8 cells2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID551375Cytotoxicity against human HT1080 assessed as inhibition of cell growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
AID1633072Cytotoxicity against human HepG2/ADM cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.
AID1899075Resistant index, ratio IC50 for K562/Adr cells over IC50 for K562 cells
AID1428412Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay
AID1489125Cytotoxicity against human HCT8 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID1675632Cytotoxicity against human K562 cells assessed as reduction in cell viability by MTT assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1905060Resistance index, ratio of IC50 for antiproliferative activity against human paclitaxel-resistant A2780/TAX cells to IC50 for antiproliferative activity against human A2780 cells2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1525111Cytotoxicity against human PLC/PRF/5 cells assessed as reduction in cell viability by MTT assay2019Journal of natural products, 05-24, Volume: 82, Issue:5
Strepantibins A-C: Hexokinase II Inhibitors from a Mud Dauber Wasp Associated Streptomyces sp.
AID1489122Cytotoxicity against human Hep2 cells assessed as reduction in cell viability after 24 hrs by CCK-8 assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
AID1421555Antiproliferative activity against human LS180 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1291708Antitumor activity against human HepG2 cells xenografted with nude mouse assessed as tumor volume at 5 mg/kg, iv administered every 2 days for 31 days (Rvb = 103.6 +/- 1.77 mm3)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
AID1478727Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity.
AID599172Cytotoxicity against human HeLa cells after 2 days2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
AID1308397Activity at PgP in human U2OS/DX500 cells assessed as Vmax measured per mg of protein incubated for 20 mins by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1405492Antiproliferative activity against human U87 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1491063Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Inflammation Modulatory Phorbol Esters from the Seeds of Aquilaria malaccensis.
AID1171351Cytotoxicity against adriamycin-resistant human MCF7 cells after 48 hrs by MTT assay2014ACS medicinal chemistry letters, Nov-13, Volume: 5, Issue:11
Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.
AID1498377Antiproliferative activity against mouse L929 cells after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
AID1894983Anticancer activity against mouse P388 cells assessed as cell growth inhibition2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID735845Cytotoxicity against human A549 cells after 72 hrs by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Cytotoxic polyketide derivatives from the South China Sea sponge Plakortis simplex.
AID633821Cytotoxicity against human MDA-MB-231 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID478256Cytotoxicity against human vinblastine-resistant KBV1 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID569465Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
AID1675626Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID551371Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID484662Cytotoxicity against human PC3 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID512160Cytotoxicity against human A2780 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1441126Cytotoxicity against human DU145 cells assessed as decrease in cell viability up to 8 uM after 48 hrs in absence of pan-caspase inhibitor QVD-OPh by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1421549Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth at 1 uM after 72 hrs by sulforhodamine B assay relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
AID1358364Increase in tumor initiating cell frequency in human PANC1 cells xenografted in BALB/c nude mouse at 0.5 uM measured after 7 days2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1638228Selectivity ratio of IC50 for human Bel7042 cells to IC50 for human Bel7402/5-FU cells2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1577578Antiproliferative activity against human HCT15 cells measured after 72 hrs by EZ-Cytox assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
AID467762Cytotoxicity against human HL60 cells by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
AID1637324Induction of apoptosis in human HeLa cells assessed as late apoptotic cells at 3 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometric analysis (Rvb = 31.80 +/- 0.25 %)2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID592930Cytotoxicity against human KB cells by sulforhodamine B method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents.
AID1185781Growth inhibition of human PC3 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1164701Cytotoxicity against human DU145 cells after 24 hrs by MTT assay2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Notolutesins A-J, dolabrane-type diterpenoids from the Chinese liverwort Notoscyphus lutescens.
AID1899069Antiproliferative activity against human KB/VCR cells measured after 72 hrs by SRB assay
AID1697197Cytotoxicity against human SW620 cells by colorimetric method2020Bioorganic & medicinal chemistry letters, 11-15, Volume: 30, Issue:22
Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
AID1833616Cytotoxicity against human HL-60 cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay2021Journal of natural products, 11-26, Volume: 84, Issue:11
Sublyratins A-O, Labdane-Type Diterpenoids from
AID1441895Antiproliferative activity against human K562 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
AID1625416Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Bafilomycins and Odoriferous Sesquiterpenoids from Streptomyces albolongus Isolated from Elephas maximus Feces.
AID1612621Antiproliferative activity against human taxol-resistant A549/TR cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1902315Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, Mar-15, Volume: 232Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
AID734084Growth inhibition against human LoVo cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID490204Cytotoxicity against human HepG2 cells by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-01, Volume: 20, Issue:13
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
AID1172770Anti-proliferative activity against human ACHN cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1541624Cytotoxicity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2019Journal of natural products, 12-27, Volume: 82, Issue:12
Glucoconjugated Monoterpene Indole Alkaloids from
AID1751129Cytotoxicity against human HT-29 cells assessed as reduction in cell viability by MTT assay
AID1783255Cytotoxicity against human NCI-H1299 cells assessed as inhibition of proliferation incubated for 72 hrs by MTT assay
AID1308430Cytotoxicity in rat H9c2 cells assessed as reduction in ROS level at 5 uM incubated for 24 hrs in presence of NAC by DCFDA-AM probe-based fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1880230Antiproliferative activity against human NCI-H358 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay2022ACS medicinal chemistry letters, May-12, Volume: 13, Issue:5
Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.
AID1611342Binding affinity to human telomeric 7 G-quadruplex DNA assessed as binding constant Kb22019Bioorganic & medicinal chemistry, 12-15, Volume: 27, Issue:24
Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]
AID1505077Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Ophiobolins from the Mangrove Fungus Aspergillus ustus.
AID1880232Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay2022ACS medicinal chemistry letters, May-12, Volume: 13, Issue:5
Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.
AID473422Anticancer activity against human SF295 cells assessed as cell growth inhibition at 10 uM after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
AID1638226Cytotoxicity against human A549 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID454057Cytotoxicity against human DU145 cells at 10 uM by MTT assay2009Bioorganic & medicinal chemistry, Nov-01, Volume: 17, Issue:21
Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
AID1145593Cytotoxicity against human HeLa cells assessed as cloning efficiency after 8 hrs1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.
AID734085Growth inhibition against human HeLa cells after 72 hrs by inverted microscopy2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
AID138188Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 16 mg/kg1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1308398Activity at PgP in human U2OS/DX500 cells assessed as Km of compound measured per mg of protein incubated for 20 mins by fluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1490962Cytotoxicity against human NCI-H1975 cells after 24 hrs by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1671738Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
AID1490959Cytotoxicity against human HeLa cells after 24 hrs by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1637319Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 2 days by MTT assay2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1405493Cytotoxicity against human FHC cells2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1625835Antitumor activity against P-gp overexpressing human MCF7/ADR cells xenografted in mouse assessed as tumor growth inhibition at 4 mg/kg, iv qd administered every 2 days measured during compound dosing2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1202749Growth inhibition of mouse B16 cells by MTT method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
1,19-seco-Avermectin analogues from a ΔaveCDE mutant Streptomyces avermectinius strain.
AID456255Cytotoxicity against human HeLa cells after 4 days by ELISA reader assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
AID1405488Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID1378625Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1363193Antiproliferative activity against human HCT15 cells after 72 hrs by EZ-CYTOX reagent based assay2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.
AID166707Inhibition of [3H]uridine incorporation into proliferating L1210 cells.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1337588Antiproliferative activity against human HCT15 cells measured after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
AID1879216Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships.
AID1637343Cytotoxicity against human MCF7 cells assessed as cell viability at 1 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1172775Anti-proliferative activity against human PC3 cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1887829Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
AID1481836Resistance factor, ratio of IC50 for human K562/ADR cells to IC50 for human K562 cells2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
AID1435297Cytotoxicity against 7 mW/cm'2 irradiated human fibroblasts at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID97979Dose required to inhibit the RNA synthesis in leukemia L1210 cells1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1308401Cytotoxicity in human U2OS/DX580 cells at 5 uM incubated for 24 hrs by LDH release-based spectrofluorimetrical analysis2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID619821Cytotoxicity against human A375 cells by MTT assay2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
AID1358348Cytotoxicity against human PANC1 cells after 72 hrs under hypoxic condition by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1441897Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
AID1546805Cytotoxicity against human HCT116 cells after 24 hrs by SRB method2020Journal of natural products, 01-24, Volume: 83, Issue:1
Prenylated
AID1490960Cytotoxicity against human NB4 cells after 72 hrs by MTT assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1331839Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 48 hrs by SRB assay2016Journal of natural products, 09-23, Volume: 79, Issue:9
Isolation of Coralmycins A and B, Potent Anti-Gram Negative Compounds from the Myxobacteria Corallococcus coralloides M23.
AID1287953Cytotoxicity against human HeLa cells after 3 days by CCK8 assay2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.
AID551376Cytotoxicity against human DWD assessed as inhibition of cell growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
AID249856Percent control of human mammary adenocarcinoma MCF-7 cell line proliferation at 30 ng/mL2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
AID1490966Cytotoxicity against human HCT116 cells after 24 hrs by sulforhodamine B assay2017Journal of natural products, 05-26, Volume: 80, Issue:5
Geranylpyrrol A and Piericidin F from Streptomyces sp. CHQ-64 ΔrdmF.
AID1663790Inhibition of human DNA topoisomerase 2 catalytic activity using supercoiled pRYG DNA as substrate measured after 45 mins in presence of ATP by agarose gel electrophoresis2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Synthesis and evaluation of novel sulfonamide analogues of 6/7-aminoflavones as anticancer agents via topoisomerase II inhibition.
AID1326529Antiproliferative activity against human ER-positive MCF7 cells measured after 48 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Discovery and development of natural product oridonin-inspired anticancer agents.
AID1378626Cytotoxicity against human A549 cells after 72 hrs by MTT assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1171350Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2014ACS medicinal chemistry letters, Nov-13, Volume: 5, Issue:11
Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.
AID478253Cytotoxicity against human HL60 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1699969Antiproliferative activity against human K562 cells by MTT assay2020Bioorganic & medicinal chemistry letters, 12-15, Volume: 30, Issue:24
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
AID548271Antiviral activity against Ebolavirus infected in african green monkey COS1 cells assessed as inhibition of viral replication after 32 hrs by luciferase reporter gene assay2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.
AID650182Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID1888033Antiproliferative activity against human HCT-15 cells after 72 hrs by EZ-Cytox colorimetric assay2022European journal of medicinal chemistry, Jan-05, Volume: 227Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.
AID1358361Inhibition of ALDH in human PANC1 cells assessed as aldefluor positive cells at 0.5 uM after 72 hrs by aldefluor assay (Rvb = 12.5%)2018European journal of medicinal chemistry, May-10, Volume: 151Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
AID1172771Anti-proliferative activity against human HCT15 cells by XTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
AID1264614Cytotoxicity against human A549 cells after 72 hrs by MTT assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.
AID1308435Induction of intracellular ROS accumulation in human U2OS/DX30 cells at 5 uM incubated for 24 hrs by DCFDA-AM probe-based fluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1895014Anticancer activity against human MCF7 cells assessed as inhibition of cell growth by MTT assay2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID580235Cytotoxicity against human SGC7901 cells assessed as cell mortality after 20 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Mar-01, Volume: 21, Issue:5
Substrate-controlled chemoselective synthesis and potent cytotoxic activity of novel 5,6,7-triarylpyrido[2,3-d]pyrimidin-4-one derivatives.
AID1673405Antiproliferative activity against drug- resistant human K562/ADR cells2019Bioorganic & medicinal chemistry, 07-15, Volume: 27, Issue:14
Design, synthesis, and biological activity evaluation of (-)-6-O-desmethylantofine analogues as potent anti-cancer agents.
AID1713808Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 2 days by cell counting kit-8 assay2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
AID1435286Dark toxicity in human M14 cells assessed as increase in nitrite levels at 5 uM measured after 20 mins by Griess reagent based spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID592698Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B based ELISA2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
AID478296Induction of apoptosis in human 518A2 cells assessed as increase of ratio of Bax to Bcl-2 mRNA expression at 5 uM after 6 to 18 hrs by RT-PCR analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1164700Cytotoxicity against human PC3 cells after 24 hrs by MTT assay2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Notolutesins A-J, dolabrane-type diterpenoids from the Chinese liverwort Notoscyphus lutescens.
AID1337587Antiproliferative activity against human DU145 cells measured after 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Jan-05, Volume: 125Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
AID512164Cytotoxicity against human DWD cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID376376Antitumor activity against human SK MEL28 cells1999Journal of natural products, Nov, Volume: 62, Issue:11
Synthesis of 11,12-epoxydrim-8,12-en-11-ol, 11,12-diacetoxydrimane, and warburganal from (-)-sclareol.
AID1381567Cytotoxicity against human HeLa cells by SRB assay
AID122233Antitumor activity against mice bearing L1210 leukemia implanted ip on day 0, after treatment with single ip dose 10 mg/kg on day 1.1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID587218Cytotoxicity against human SW1116 cells assessed as cell viability rate at 10 ug/ml after 24 hrs by MTT assay2011European journal of medicinal chemistry, Mar, Volume: 46, Issue:3
Efficient microwave-assisted synthesis of novel 3-aminohexahydrocoumarin derivatives and evaluation on their cytotoxicity.
AID1650583Antiproliferative activity against human HeLa/Fucci2 cells assessed as inhibition of cell viability incubated for 3 days by MTT assay2020Bioorganic & medicinal chemistry, 01-15, Volume: 28, Issue:2
Metachromins X and Y from a marine sponge Spongia sp. and their effects on cell cycle progression.
AID633826Cytotoxicity against human HeLa cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
AID1706709Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
AID1625736Resistance index, ratio of IC50 for beta-tubulin 3 overexpressing human A2780T cells to IC50 for human A2780S cells2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID650180Cytotoxicity against human PC3 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
AID1441124Cytotoxicity against cancer stem cells derived from human BT474 cells assessed as cancer stem cell death at 7.5 uM after 3 days by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1675627Cytotoxicity against human PC-3 cells assessed as reduction in cell viability by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Monacycliones G-K and
AID1498578Resistance factor, ratio of IC50 for human MCF7/ADR cells to IC50 for human MCF7 cells2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
AID1524519Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
AID1608426Growth inhibition of human MCF7 cells after 48 hrs by SRB assay2019European journal of medicinal chemistry, Oct-15, Volume: 180Role of sulphur-heterocycles in medicinal chemistry: An update.
AID1436220Cytotoxicity against human HeLa cells assessed as cell growth at 10'-7 M after 48 hrs by SRB assay relative to control2017European journal of medicinal chemistry, Jan-27, Volume: 126Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
AID689426Cytotoxicity against BALB mouse 3T3 cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
AID1633075Potency index, ratio of IC50 for human HepG2/ADM cells to IC50 for human HepG2 cells2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.
AID1882815Antitumor activity against mouse Sarcoma-180 cells xenografted in ip dosed ICR mouse assessed as tumor growth inhibition rate administered daily for 7 days relative to control2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID94923Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 2 mg/kg intraperitoneal dose1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: a novel class of anthracycline derivatives.
AID1185780Growth inhibition of human Bcap37 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
AID1398449Cytotoxicity against human A549 cells after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.
AID1461758Cytotoxicity against human wild-type MCF7 cells after 72 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID478300Induction of apoptosis in human 518A2 cells assessed as increase of Bax mRNA expression at 5 uM up to 24 hrs by Western blot analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1168507Cytotoxicity against human A172 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Synthesis and biological evaluation of a novel class of coumarin derivatives.
AID566856Cytotoxicity against human HL60 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1435965Cytotoxicity against human MCF7 cells assessed as growth inhibition at 10 uM measured after 72 hrs by CCK-8 assay relative to control
AID1577567Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs by CCK8 assay
AID1435307Dark toxicity against human fibroblasts at 5 uM measured after 20 mins by spectrophotometric method2017ACS medicinal chemistry letters, Mar-09, Volume: 8, Issue:3
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
AID1428413Cytotoxicity against human HeLa cells assessed as growth inhibition after 72 hrs by SRB assay
AID1504836Cytotoxicity against human MCF7 cells assessed as reduction in cell viability by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Bibenzyl-Based Meroterpenoid Enantiomers from the Chinese Liverwort Radula sumatrana.
AID1907348Cytotoxic activity against human MCF-10A assessed as inhibition of cell growth incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID1906032Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
AID478263Cytotoxicity against human topotecan-resistant MCF7 cells after 72 hrs by MTT assay in presence of 1.2 mM BCRP inhibitor fumitremorgin C2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1504838Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability by MTT assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Bibenzyl-Based Meroterpenoid Enantiomers from the Chinese Liverwort Radula sumatrana.
AID1543241Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID1374096Antiproliferative activity against human T47D cells incubated for 72 hrs by CCK8 assay2018Bioorganic & medicinal chemistry letters, 02-15, Volume: 28, Issue:4
Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.
AID512017Cytotoxicity against human A549 cells after 48 hrs by SRB assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
AID1637342Cytotoxicity against human MCF7 cells assessed as cell viability at 10 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID1352062Cytotoxicity against human K562/A02 cells assessed as reduction in cell viability after 72 hrs by MTS assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
AID1637347Cytotoxicity against human HeLa cells assessed as cell viability at 20 uM after 2 days by MTT assay relative to control2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
AID473261Anticancer activity against human MCF7 cells assessed as cell growth inhibition at 10 uM after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
AID1370455Cytostatic activity against human HepG2 cells assessed as cell viability at 0.02 to 70 uM after 48 hrs by MTS assay2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
AID1431560Selectivity ratio of IC50 for human KG1a cells to IC50 for human HL60 cells2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
AID1486981Cytotoxicity against human K562 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
AID587221Cytotoxicity against human SGC7901 cells after 20 hrs by MTT assay2011European journal of medicinal chemistry, Mar, Volume: 46, Issue:3
Efficient microwave-assisted synthesis of novel 3-aminohexahydrocoumarin derivatives and evaluation on their cytotoxicity.
AID1188101Cytotoxicity against human HCT116 cells assessed as growth inhibition at 1 uM after 48 hrs by sulforhodamine B assay2014European journal of medicinal chemistry, Oct-06, Volume: 85Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies.
AID1374097Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK8 assay2018Bioorganic & medicinal chemistry letters, 02-15, Volume: 28, Issue:4
Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.
AID1875134Growth inhibition of human MDA-MB-231 cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID1905035Antiproliferative activity against human A2780 cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1288092Cytotoxicity against human HCT15 cells after 48 hrs by CCK8 assay2016European journal of medicinal chemistry, May-04, Volume: 113A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.
AID718787Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Angucyclines from an insect-derived actinobacterium Amycolatopsis sp. HCa1 and their cytotoxic activity.
AID1887103Cytotoxicity against human ASPC1 cells assessed as reduction in cell viability by SRB assay
AID1617196Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus
AID1611341Binding affinity to human telomeric 7 G-quadruplex DNA assessed as binding constant Kb12019Bioorganic & medicinal chemistry, 12-15, Volume: 27, Issue:24
Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]
AID103256Cytotoxicity against MCF-7R cell line in the purdue cell culture screen was determined1999Bioorganic & medicinal chemistry letters, Feb-08, Volume: 9, Issue:3
On the relationship of OSW-1 to the cephalostatins.
AID111014Myocardial histopathological effect in female mice treated iv at a dose of 4.0 mg/kg twice weekly on weeks 1, 2, 5, 6 & 7 is measured as no. of mice with myocardial vacuolization/no. of mice examined; Inactive1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Intensely potent morpholinyl anthracyclines.
AID1337470Inhibition of human DNA topoisomerase-1 at 20 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control2017European journal of medicinal chemistry, Jan-05, Volume: 125Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
AID1907349Selectivity index, ratio of IC50 for Cytotoxic activity against human MCF-10A cells to IC50 for antiproliferative activity against human MDA-MB-231 cells2022European journal of medicinal chemistry, Jun-05, Volume: 236Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
AID1308432Cytotoxicity in rat H9c2 cells assessed as reduction in ROS level at 5 uM incubated for 24 hrs in presence of dexrazoxane by LDH release-based spectrofluorimetrical analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
AID1696720Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay2020Journal of natural products, 09-25, Volume: 83, Issue:9
Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by
AID549505Cytotoxicity against human A549 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Efficient synthesis and biological evaluation of epiceanothic acid and related compounds.
AID1386172Cytotoxicity against human A2780 cells after 48 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Cytotoxic p-Terphenyls from the Endolichenic Fungus Floricola striata.
AID1378628Antifungal activity against Peronophythora litchii after 8 hrs by conidial germination assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.
AID1899073Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay
AID380471Cytotoxicity against MDR1-G185 overexpressing human HeLa cells by MTT assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Sylviside, a diterpene glucoside derivative from Gnaphalium sylvaticum.
AID1227996Cytotoxic activity against human BGC823 cells by MTT method2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.
AID380470Cytotoxicity against wild type human HeLa cells by MTT assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Sylviside, a diterpene glucoside derivative from Gnaphalium sylvaticum.
AID478277Induction of apoptosis in human 518A2 cells assessed as increase of caspase 9 activity at 5 uM after 8 to 12 hrs by luminometric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1426656Resistant factor, ratio of IC50 for P-gp overexpressing/drug resistant human K562/A02 cells to IC50 for human K562 cells2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
AID1673406Antiproliferative activity against human K562 cells2019Bioorganic & medicinal chemistry, 07-15, Volume: 27, Issue:14
Design, synthesis, and biological activity evaluation of (-)-6-O-desmethylantofine analogues as potent anti-cancer agents.
AID150546In vitro inhibitory activity against cancerous P388 cell line2004Journal of medicinal chemistry, Jan-29, Volume: 47, Issue:3
A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives.
AID1625718Antiproliferative activity against human HCT8 cells after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
AID1268504Cytotoxicity against human HepG2 cells after 48 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
AID138189Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 1 mg/kg1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin.
AID1408891Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
AID1815017Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021Journal of natural products, 08-27, Volume: 84, Issue:8
Cryptoyunnanones A-H, Complex Flavanones from
AID478295Induction of apoptosis in human HL60 cells assessed as increase of ratio of Bax to Bcl-2 mRNA expression at 5 uM after 6 to 18 hrs by RT-PCR analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1762048Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
AID484656Cytotoxicity against human HOP62 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID1638224Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Mar-01, Volume: 165Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
AID1281576Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay2016European journal of medicinal chemistry, Mar-23, Volume: 111Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
AID1441110Cytotoxicity against human BT474 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1227995Cytotoxic activity against human HepG2 cells by MTT method2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Dimeric Abietane Diterpenoids and Sesquiterpenoid Lactones from Teucrium viscidum.
AID478297Induction of apoptosis in human HL60 cells assessed as increase of Bcl-2 mRNA expression at 5 uM up to 24 hrs by Western blot analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID509754Cytotoxicity against human KB cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
AID1594692Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID1459361Cytotoxicity against human MG63 cells by MTT assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Bissubvilides A and B, Cembrane-Capnosane Heterodimers from the Soft Coral Sarcophyton subviride.
AID248714Concentration required to inhibit proliferation of human mammary adenocarcinoma MCF-7 cell line was determined using MTT assay2004Bioorganic & medicinal chemistry letters, Sep-20, Volume: 14, Issue:18
Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
AID1401031Selectivity ratio of GI50 for human MCF7 cells to GI50 for human MCF7/ADR cells2017European journal of medicinal chemistry, Dec-01, Volume: 141Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
AID1431559Cytotoxicity against human HL60 cells assessed as decrease in cell proliferation after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
AID1890788Cytotoxicity against human NCI-H23 cells assessed as cell growth inhibition incubated for 48 hrs by SRB method2022Journal of natural products, 04-22, Volume: 85, Issue:4
Isolation, Structure Determination, and Semisynthesis of Diphenazine Compounds from a Deep-Sea-Derived Strain of the Fungus
AID1405490Antiproliferative activity against human PANC1 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
AID689429Cytotoxicity against human LoVo cells after 72 hrs by SRB assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
AID1390170Antiproliferative activity against human HeLa cells after 72 hrs by CCK-8 assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents.
AID333312Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1711795Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 06-15, Volume: 26, Issue:12
Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
AID1543245Cytotoxicity in human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 07-26, Volume: 82, Issue:7
Prenylated Bibenzyls from the Chinese Liverwort
AID1363194Antiproliferative activity against human T47D cells after 72 hrs by EZ-CYTOX reagent based assay2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.
AID1566583Cytotoxicity against human Bcap37 cells2019European journal of medicinal chemistry, Sep-01, Volume: 177Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
AID1905056Antiproliferative activity against human adriamycin-resistant A549/ADR cells assessed as cell viability incubated for 48 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID1879219Antiproliferative activity against human HeLa cells assessed as inhibition of cell proliferation2022Bioorganic & medicinal chemistry letters, 03-15, Volume: 60Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships.
AID1875131Growth inhibition of human NCI-H23 cells by SRB assay2022Journal of natural products, 09-23, Volume: 85, Issue:9
Aspersterols A-D, Ergostane-Type Sterols with an Unusual Unsaturated Side Chain from the Deep-Sea-Derived Fungus
AID510625Cytotoxicity against human MCF7 cells after 4 days by MTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
AID1437481Cytotoxicity against human HeLa cells assessed as reduction in cell viability by SRB assay2017Journal of natural products, 01-27, Volume: 80, Issue:1
Penicisulfuranols A-F, Alkaloids from the Mangrove Endophytic Fungus Penicillium janthinellum HDN13-309.
AID478298Induction of apoptosis in human HL60 cells assessed as increase of Bax mRNA expression at 5 uM up to 24 hrs by Western blot analysis2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
AID1612620Drug resistance index, ratio of IC50 for taxol-resistant human HCT8/T cells to IC50 for human HCT8 cells2019European journal of medicinal chemistry, Feb-01, Volume: 163Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
AID1524518Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
AID1594691Cytotoxicity in human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Asperunguisins A-F, Cytotoxic Asperane Sesterterpenoids from the Endolichenic Fungus Aspergillus unguis.
AID378842Cytotoxicity against human VA13 cells2006Journal of natural products, Oct, Volume: 69, Issue:10
Bioactive guaianolides from siyekucai (Ixeris chinensis).
AID1757284Antiproliferative activity against VCR resistant human K562/VCR cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2021European journal of medicinal chemistry, Apr-15, Volume: 216Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
AID484659Cytotoxicity against human DWD cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates.
AID510626Cytotoxicity against human HCT116 cells after 4 days by MTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
AID1441112Cytotoxicity against human PC3 cells assessed as cell death at 2 to 25 times CC50 after 48 hrs by MTS assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347124qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347128qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347129qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347137qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for Daoy cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347140qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347141qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347136qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347112qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347126qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347111qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347113qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347122qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347115qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347121qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347119qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347114qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347110qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells)2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347117qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347118qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347138qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D caspase screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347116qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347127qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347109qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347139qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347135qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Orthogonal 3D viability screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347123qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347125qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (280)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.43)18.7374
1990's7 (2.50)18.2507
2000's16 (5.71)29.6817
2010's195 (69.64)24.3611
2020's58 (20.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews15 (5.42%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
Other262 (94.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (17)

ArticleYear
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
Journal of medicinal chemistry, 03-09, Volume: 60, Issue: 5
2017
In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone.
Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue: 19
2016
Design, structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives/analogues.
European journal of medicinal chemistry, Oct-04, Volume: 121
2016
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
Journal of medicinal chemistry, 05-26, Volume: 59, Issue: 10
2016
Structure activity relationship, cytotoxicity and evaluation of antioxidant activity of curcumin derivatives.
Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue: 4
2016
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue: 13
2015
Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
European journal of medicinal chemistry, May-06, Volume: 78
2014
Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
European journal of medicinal chemistry, Volume: 62
2013
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue: 5
2012
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue: 1
2012
Efficient microwave-assisted synthesis of novel 3-aminohexahydrocoumarin derivatives and evaluation on their cytotoxicity.
European journal of medicinal chemistry, Volume: 46, Issue: 3
2011
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chemical research in toxicology, Jul-19, Volume: 23, Issue: 7
2010
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
European journal of medicinal chemistry, Volume: 45, Issue: 7
2010
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue: 9
2010
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue: 1
2010
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue: 1
2010
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
Journal of medicinal chemistry, Volume: 21, Issue: 8
1978
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (7)

ArticleYear
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
European journal of medicinal chemistry, Apr-05, Volume: 233
2022
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
Bioorganic & medicinal chemistry, 08-01, Volume: 28, Issue: 15
2020
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, Volume: 96, Issue: 5
2019
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46
2019
Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
European journal of medicinal chemistry, Sep-01, Volume: 177
2019
Discovery and development of natural product oridonin-inspired anticancer agents.
European journal of medicinal chemistry, Oct-21, Volume: 122
2016
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
Journal of medicinal chemistry, Oct-09, Volume: 57, Issue: 19
2014
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1)

ArticleYear
Intensely potent morpholinyl anthracyclines.
Journal of medicinal chemistry, Volume: 27, Issue: 5
1984
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
Inflammation Modulatory Phorbol Esters from the Seeds of Aquilaria malaccensis.
Journal of natural products, 05-26, Volume: 80, Issue: 5
2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]